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Aberrations in chromosome 7, either due to monosomy or partial deletion of 7q, are 
commonly associated with leukemia. Cytogenetic studies have delineated 7q22 as a 
critical region in myeloid malignancies. A search for a candidate tumor suppressor 
gene within this region led to the identification of a novel gene, which was later 
categorized as the fifth MLL/trithorax member and designated MLL5.  
 
Since its discovery in 2002, extensive research has been directed to investigate the 
function of MLL5, particularly its roles in hematopoiesis and leukemogenesis. In 
2009, three studies from independent research groups were published in the same 
issue of Blood, and demonstrated that Mll5 is required for proper hematopoietic stem 
cell differentiation in mice. In 2011, a follow-up study on Mll5 knockout mice from 
Samuel Aparicio’s group was published, which analyzed the consequences of Mll5 
deficiency for spermatogenesis and showed that Mll5 indeed plays a role in 
mammalian spermatogenesis at the level of terminal differentiation. Although initial 
phenotypic characterization of Mll5 deficient mice reveals defects in hematopoiesis 
and spermatogenesis, the cellular function of MLL5 and its signaling targets remain 
elusive. 
 
Dr Deng first encountered an isoform of MLL5 during a screening study; she then 
cloned the full length MLL5 and carried out functional characterization on this protein. 
In her study, MLL5 was found to form intranuclear speckles, and over-expression of 
MLL5 arrested the cell cycle at G1 phase, suggesting of a role of MLL5 in growth 
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suppression. Later on, our group developed small interfering RNAs targeting at 
MLL5 to study the loss-of-function of this protein using mammalian cell culture 
system. Surprisingly, when cells are treated with MLL5-siRNA, the growth rate is 
retarded rather than accelerated. Further examination on the cell cycle status reveals 
that MLL5-depleted cells are arrested at both G1 and G2/M phases. This finding is 
very intriguing as the cellular level of MLL5 need to be properly maintained in order 
for cell cycle progression. Therefore, the main focus of Dr Deng’s research group is to 
unravel the function of MLL5 in cell cycle regulation. Currently, the involvement of 
MLL5 in cell cycle transition, in transcriptional regulation and in epigenetic control is 
under intensive investigation. 
 
This thesis proposes to make a contribution to the current understandings on the 
molecular function of MLL5. In particular, critical attempts at attending to the mitosis 
phase of the cell cycle are pursued in order to build a complete picture of MLL5 in the 
cell cycle regulation. In the first part of the results section (Chapter 3), the cell-cycle 
dependent expression and post-translational modification of MLL5 are examined, and 
how the post-translational modification on MLL5 in turn regulates the cell cycle 
progression is also discussed. Briefly, the expression of MLL5 is relatively constant 
throughout the cell cycle; however in mitosis phase MLL5 is heavily phosphorylated 
in a Cdk1-dependent manner. Moreover, perturbation on the phosphorylation 
modification of MLL5 results in cell cycle arrest at G2 phase, suggesting that 
phosphorylation of MLL5 and the dissociation of MLL5 from chromatin may be 
required for mitotic entry.  
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During the study, another interesting observation was made that MLL5-depleted cells 
experienced abnormal cell division. Hence, the function of MLL5 at mitosis was 
further pursued and the findings are presented in the second part of the results section 
(Chapter 4). The primary discovery is that MLL5-depleted cells fail to align 
chromosomes at metaphase and exit mitosis without chromosome segregation and 
cytokinesis, which are attributed to the degradation of the chromosomal passenger 
complex. Mechanistic study reveals that MLL5 directly interacts with one subunit of 
the chromosomal passenger complex-Borealin. Depletion of MLL5 renders Borealin 
protein unstable which further leads to the degradation of the other three subunits 
before mitotic entry. The loss of chromosomal passenger complex function 
compromises the fidelity of cell division and results in chromosome instability. These 
data provide compelling evidence that MLL5 has a clear role in maintaining genomic 
stability by modulating the assembly and stability of the chromosomal passenger 
complex. 
 
Conclusively, this study provides mechanistic insights into the post-translational 
regulation and molecular signaling of MLL5 at mitotic entry and maintenance of 
genomic integrity. The evidences presented in this thesis contribute to the 
understanding of MLL5 in the context of cell cycle regulation and gives a new 
direction for future investigation on MLL5.  
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1.1 Mitosis and its regulation 
1.1.1 Overview of the mammalian cell cycle 
The major mission of the cell division cycle is a faithful and complete duplication of 
the genome followed by an equal partitioning of chromosomes to subsequent cell 
generations (Nurse, 2000; Pines, 1999). In order to maintain genetic and functional 
integrity, cells must progress unidirectionally through G1, S, G2 and M phases of the 
cell cycle. The G1 phase is also referred to as the growth phase. During this phase the 
cell prepares itself for DNA synthesis. The S phase is the DNA synthesis phase 
therefore it has DNA content between 2N and 4N. At the end of S phase, the DNA is 
duplicated with high replication fidelity, and the duplicated sister chromatids are tied 
together by the cohesin complex (Peters et al., 2008). The G2 phase follows the S 
phase and is another period of rapid cell growth and protein synthesis for the 
preparation of dynamic chromosomal movements during mitosis. The M phase is 
when the duplicated chromosomes separate into two identical groups through a series 
of highly coordinated events to produce two daughter cells. 
         
The driving force for promoting forward movement of the cell cycle derives from the 
sequential activation of the cyclin-dependent kinases (Cdks), which are regulated 
through the synthesis and destruction of their partner cyclins (Pines, 1999). The cyclin 
D1 forms complex with Cdk4, 6 to initiate cell cycle progression from G1 to S phase. 
In S phase, cyclin E binds to Cdk2 and activates the DNA replication progress. The 
cyclin A associates with Cdk2 to coordinate the S to G2 transition and entry into 
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mitosis.  The cyclin B/Cdk1 complex plays a major role in progression through 
mitosis. Alterations in Cdk activity induces unscheduled proliferation as well as 
genomic and chromosomal instability which often leads to tumor development 
(Malumbres and Barbacid, 2009). 
  
The cell cycle checkpoints modulate cell cycle progression in response to adverse 
conditions (Smits and Medema, 2001). The G1/S cell cycle checkpoint inhibits the 
entry into S phase in response to DNA damage, contact inhibition and growth factor 
withdrawal. It is mainly mediated by p53 where p53 regulates the transcription of the 
Cdk inhibitors (Levine, 1997). The G2/M checkpoint prevents the cell from entering 
mitosis if there is DNA damage. The G2/M DNA damage checkpoint is 
predominantly mediated by the ATM/ATR pathways through inhibiting the Cdk1 
(Lobrich and Jeggo, 2007). The cell can enter mitosis after it has passed through the 
G1/S and G2/M checkpoints; however, it is still subjected to the mitotic checkpoint 
(Spindle assembly checkpoint). This checkpoint inhibits sister chromatids separation 
by inhibiting the anaphase promoting complex/cyclosome (APC/C) until all 
chromosome are aligned at metaplate (Musacchio and Salmon, 2007). The cell cycle 
checkpoint works as a molecular surveillance system to ensure that each cell cycle 
process is appropriately completed before subsequent events are initiated. Therefore, 
any defects in the cell cycle checkpoint may cause accumulation of genetic mutation 
and subsequently lead to tumor formation (Kastan and Bartek, 2004). A general 
diagram depicting the mammalian cell cycle and the cell cycle checkpoints is 





Figure 1-1. The mammalian cell cycle. Each of the main events that take place 
during interphase (G1, S and G2) is driven by unique Cdks bound to specific cyclins. 
The G1/S checkpoint senses DNA replication stress and prevents the cell from 
entering S phase through the p53 pathway. The G2/M checkpoint inhibits mitosis 
entry if there is DNA damage, which is mediated by the ATM/ATR pathways through 
inhibiting the Cdk1. The spindle assembly checkpoint monitors kinetochore-
microtubule interactions and prevents premature anaphase onset by inhibiting the 
APC/C activity (Modified from Malumbres and Barbacid 2009). 
 
1.1.2 The M phase of the cell cycle 
Mitosis can be further divided into five stages: prophase, metaphase, anaphase, 
telophase and cytokinesis (Figure 1-2). In prophase, the chromatin progressively 
condenses by coiling to form chromosomes, the spindle apparatus has migrated to the 
opposite poles of cell, and the nucleoli are dissolved. In metaphase, the kinetochores 
of the condensed chromosomes are attached to microtubules nucleating from opposite 
spindle poles and aligned at the equatorial plate, which is also referred to as 
chromosome bi-orientation.  Chromosome alignment error occurred during the bi-
orientation process is sensed by the mitotic checkpoint and is corrected by the 
chromosomal passenger complex. Until all kinetochores are properly attached, the cell 
proceeds to anaphase. In anaphase, the APC/C is activated and degrades a series of 
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mitotic regulators including cyclin B1. The sister chromatids are separated by the 
separase and pulled apart by shortening kinetochore microtubules and move toward 
the respective spindle pole. The telophase is actually a reversal of prophase events, 
where chromosomes reach the respective spindle pole and nuclear envelope reforms. 
The last stage of mitosis is cytokinesis, and it involves the formation of cleavage 
furrow and division of cytoplasmic material into two daughter cells. 
 
 
Figure 1-2. The dynamic movements of chromosomes in mitosis. Prophase: 
chromatin progressively condenses by coiling to form chromosomes, the spindle 
apparatus has migrated to the opposite poles of cell. Metaphase, the kinetochores of 
the condensed chromosomes are attached to microtubules nucleating from opposite 
spindle poles and aligned at the equatorial plate. Chromosome alignment is monitored 
by the spindle assembly checkpoint and errors are corrected by the chromosomal 
passenger complex. Anaphase: The sister chromatids are separated by the separase 
and pulled apart by shortening kinetochore microtubules and move toward the 
respective spindle pole. Telophase: chromosomes reach the respective spindle pole 
and nuclear envelope reforms.   
 
1.1.3 The cyclin B/Cdk1 complex 
Efficient entry into mitosis requires the swift and irreversible activation of cyclin 
B/Cdk1, which is ensured through the precise spatial and temporal regulation by the 
coordinate action of positive and negative regulators. In interphase, the newly formed 
cyclin B/Cdk1 complexes are kept inactive in the cytoplasm by inhibitory 
phosphorylation on the Thr14 and Tyr15 of the Cdk1 by Wee1 and Myt1 (Perry and 
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Kornbluth, 2007). The accumulation of cyclin B at G2 phase triggers the activation of 
Cdk1 which is further enhanced by Cdc25 which dephosphorylates both the Thr14 
and Tyr15 residues of Cdk1 (Gavet and Pines, 2010). The activation of Cdk1 in turn 
modulates the activity of Wee1 and Cdc25 and forms a positive feedback loop. The 
sharp activation and propagation of Cdk1 activity ensures that entry into mitosis is 
tightly controlled and irreversible. The active Cdk1 phosphorylates a multitude of 
substrates, leading to dramatic cellular rearrangements, including the breakdown of 
the nuclear envelope, chromosome condensation, the dissociation of transcription 
factors from condensed chromosome and the assembly of a mitotic spindle (Holt et al., 
2009; Ubersax et al., 2003). Inhibition of Cdk1 activity by a reversible small molecule 
inhibitor (RO-3306) arrests human cells at late G2 phase, further suggesting that Cdk1 
is required for mitotic entry (Vassilev et al., 2006).  
  
1.1.4 The spindle assembly checkpoint 
During mitosis, the sister chromatids attach to spindle microtubules through their 
kinetochores. To ensure equal distribution of the genetic material, the two sister 
kinetochores must attach to microtubules from opposite spindle poles. The spindle 
assembly checkpoint serves as a surveillance system to monitor the kinetochore-
microtubule interactions. It inhibits the activity of APC/C and delays the onset of 
anaphase until all chromosomes achieve bi-orientation (Musacchio and Hardwick, 
2002). The spindle checkpoint senses both the attachment of microtubules to 
kinetochores and the tension generated between sister kinetochores upon bipolar 
attachment (Figure 1-3). Although the precise mechanism of action of the spindle 
checkpoint is still under intensive study, it is clear that both the MAD2 and BubR1 
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play important roles. Studies have shown that MAD2 is recruited to unattached 
kinetochores, and prevents the activation of APC/C by directly forming a MAD2-
CDC20-APC complex (Fang et al., 1998; Sironi et al., 2001; Skoufias et al., 2001). 
Whereas BubR1 can be independently recruited to kinetochores in response to loss-
of-tension between sister kinetochores without the activation of MAD2 (Skoufias et 
al., 2001), suggesting that BubR1 may have independent roles in spindle checkpoint 
response by sensing the sister kinetochore tension. Besides their separate functions in 
sensing the attachment and tension, the checkpoint protein MAD2 and BubR1 can 
also act cooperatively to prevent premature separation of sister chromatids by forming 




Figure 1-3. Modes of kinetochore-microtubule interactions and spindle checkpoint activation. Amphitelic attachment: each sister 
kinetochore attaches to microtubules extending from opposite spindle poles, and generates inter-kinetochore tension across the centromere 
region. As a result, the spindle checkpoint is inactivated since both kinetochore attachment and interkinetochore tension are detected. Syntelic 
attachment: Both sister kinetochores attach to microtubules extending from one spindle pole. As a result, there is no tension being generated 
between sister kinetochore, the spindle checkpoint is activated. Merotelic attachment: one sister kinetochore simultaneously attaches to 
microtubules extending from both spindle poles. As a result, the spindle checkpoint is activated due to failure in generating inter-kinetochore 
tension. Monotelic attachment: one of the sister kinetochores attaches to microtubules, whereas the other does not attach to any microtubules. As 
a result, the spindle checkpoint is activated due to unattached kinetochore and failure in generating inter-kinetochore tension (Modified from 
Tomoyuki et al. 2009). 
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1.1.5 The chromosomal passenger complex 
Human chromosomal passenger complex (CPC) is a critical regulator of chromosome 
segregation during mitosis. It comprises the Aurora-B kinase and three non-enzymatic 
regulatory subunits, Survivin, Borealin and INCENP (Ruchaud et al., 2007). The 
expression of CPC is cell cycle dependent, with minimal expression in G1/S, and 
gradually increases during G2 phase and peaks at M phase (Honda et al., 2003; Terada 
et al., 1998; Zhao et al., 2000). CPC initially localizes to the chromosome arms to 
control the chromosome structure and organization, subsequently concentrates on the 
inner centromeres to promote the kinetochore-microtubule (MT) interactions 
(Ruchaud et al., 2007). At anaphase and telophase, CPC transfers to the spindle 
midzone, the equatorial cortex and to the midbody, where it is essential for the 
cytoplasmic division.   
 
One of the key events orchestrated by the CPC is the correction of the kinetochore 
MT attachment errors, which is dependent on the kinase activity of Aurora-B through 
phosphorylating kinetochore-localized microtubule-capture factors (Vader et al., 
2006). It has been demonstrated that Aurora B can phosphorylate the Hec1/Ndc80 
complex and such phosphorylation reduces the affinity of Hec1/Ndc80 for 
microtubules (DeLuca et al., 2006). Aurora B also promotes the release of improper 
microtubule attachments by phosphorylating MCAK (mitotic-centromere-associated 
kinesin) (Knowlton et al., 2006). As a consequence, the reduced stability or affinity of 
the kinetochore-MT interactions generate unattached kinetochores, which allow the 
reattachment to occur. Meanwhile, the unattached kinetochore activates the spindle 
assembly checkpoint and inhibits the anaphase onset. More recently, CPC has also 
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been shown to activate the spindle checkpoint directly through regulating the 
kinetochore level of BubR1 (Ditchfield et al., 2003; Morrow et al., 2005). 
Collectively, the CPC ensures chromosome bi-orientation through promoting the 
turnover of kinetochore-MT interactions and maintains mitotic fidelity by regulating 
the spindle assembly checkpoint, which is summarized in Figure 1-4. 
   
 
Figure 1-4. The CPC maintains mitotic fidelity by correcting chromosome 
misalignment and regulating the spindle assembly checkpoint. The CPC senses 
and corrects faulty attached kinetochore-MT interactions by phosphorylating 
kinetochore components like Hec1/Ndc80 complex and MCAK, which induces the 
destabilization of microtubules and generates unattached kinetochores. New rounds of 
attachment between kinetochore-MT occur until bi-orientation is achieved. The CPC 
also elicits a spindle checkpoint response directly through regulating the BubR1 and 
indirectly through the unattached kinetochore to inhibit the APC/C and anaphase 





Within the chromosomal passenger complex, the four subunits interact extensively. 
Borealin oligomerizes in its isolated form and it forms subcomplex with Survivin, 
which is competent for interaction with INCENP, and is implicated in the centromere-
targeting of the CPC (Zhou et al., 2009). Survivin can bind to the other three complex 
members. Aurora B interacts with INCENP and this binary subcomplex may have 
centromere-independent functions (Ruchaud et al., 2007). It has been shown that the 
recruitment of CPC to the centromere is mediated by the Cdk1-dependent 
phosphorylation of Borealin which promotes its interaction with the centromeric 
adaptor Shugoshin (Tsukahara et al., 2010; Yamagishi et al., 2010), and by the 
phosphorylation of Thr3 on histone H3 which recruits Survivin onto the centromeric 
region of the chromatin (Kelly et al., 2010; Wang et al., 2010; Yamagishi et al., 2010). 
The interactions among the subunits not only regulate the centromere targeting of the 
complex, but also maintain the complex stability. Depletion of any member of the 
CPC by RNA interference delocalizes the complex, renders it unstable and disrupts 
mitotic progression (Honda et al., 2003; Klein et al., 2006). 
 
1.2 Overview of the mammalian Mixed Lineage Leukemia protein family 
The polycomb group (PcG) and trithorax group (TrxG) proteins form the molecular 
basis of the cellular memory during development, where differential gene-expression 
patterns defining the specific cell types are maintained during DNA replication and at 
mitosis (Ringrose and Paro, 2004). Molecular analysis reveals that PcG and TrxG 
form large protein complex and modify the local conformation of chromatin to 
maintain transcriptional repression or activation of their target genes respectively. A 
well studied target of the PcG and TrxG is the Hox genes, which encode a highly 
conserved class of transcription factors regulating numerous pathways during 
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developmental and normal cellular processes (Svingen and Tonissen, 2006). 
Mutations in Hox genes may result in the transformation of one body segment into the 
identity of another (Breen et al., 1995; Favier and Dolle, 1997). 
 
The PcG and TrxG proteins are well conserved throughout evolution. Mixed Lineage 
Leukemia (MLL) is the established mammalian homologue of Trx, which is critical in 
the maintenance of Hox gene expression during development. Heterozygous Mll-
knockout mice show posterior shifts in the pattern of Hox gene expression, and 
homozygous Mll-knockout mice cannot maintain the expression pattern of Hox genes 
which leads to embryonic lethality (Yu et al., 1998). To date, five members have been 
identified within the MLL family, and MLL is still the best characterized among them 
(Figure 1-5). A common feature of the MLL protein family is the concomitant 
presence of a variable number of plant homeodomain (PHD) zinc fingers and a single 
Su (var) 3-9, enhancer-of-zester and trithorax (SET) domain. Studies have shown that 
PHD fingers are binding or recognition modules for histone modification, whereas the 
SET domain possesses methyltransferase activity (Mellor, 2006; Milne et al., 2002; 
Nakamura et al., 2002).  
 
1.2.1 Mixed Lineage Leukemia in epigenetic regulation 
The roles for the methyltransferase activity of the SET domain in epigenetic 
regulation have been extensively studied in the MLL protein family, which are able to 
methylate lysine residue at histone H3 and thereby influence the transcriptional state 
of target genes. MLL1 and MLL2 form a protein complex containing menin, WDR5, 
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and chromatin-remodeling components and are implicated in the regulation of Hox 
gene expression (Hughes et al., 2004; Wysocka et al., 2005; Yokoyama et al., 2004). 
MLL3 and MLL4/ALR are found in complexes containing ASC-2 where their histone 
lysine methyltransferase activities are often associated with H3 acetylation and 
H3K27 demethylation (Lee et al., 2007; Lee et al., 2006; Nightingale et al., 2007). 
However, the methyltransferase activity of MLL seems dispensable for embryonic 
development, as mice harboring a homozygous deletion of only the SET domain are 
born at normal Mendelian ratios with mild phenotypes (Terranova et al., 2006). In 
contrast, MLL-null mice are embryonic lethal (Yu et al., 1995). Therefore, it is very 
likely that MLL also serves methyltransferase-independent functions to maintain 
active chromatin.  
 
 
 Figure 1-5. Schematic representation of MLL family proteins. The graph was 
constructed based on the domain analysis using SMART program (http://smart.embl-
heidelberg.de/). The evolutionary relationship among MLL family members was 
drawn based on the cladogram from ClustalW (http://www.ebi.ac.uk/Tools/clustalw/) 





1.2.2 Mixed Lineage Leukemia in cell cycle regulation 
The intricate interplay between MLL family members and the cell cycle machinery 
has also been documented (Liu et al., 2007; Takeda et al., 2006; Tyagi et al., 2007). 
MLL undergoes site-specific proteolysis by an evolutionarily conserved protease 
Taspase I to generate an MLL
N320/C180
 heterodimer, which is required for the full 
activation of MLL. The active MLL directly participates in cell cycle progression 
through an MLL-E2F axis which controls the transcription of Cyclins (Takeda et al., 





 target MLL for degradation at S phase and late M phase 
to ensure orchestrated cell cycle progression (Liu et al., 2007; Takeda et al., 2006). 
Recently, the role of MLL in facilitating the inheritance of active gene expression 
states during mitosis has been elucidated. MLL is found to associate with condensed 
mitotic chromosomes and binds to specific gene promoters which are highly 
transcribed during interphase; thus the retention of MLL at gene promoters during 
mitosis facilitates transcriptional reactivation following mitotic exit (Blobel et al., 
2009). Surprisingly, the effects of MLL on post-mitotic gene reactivation seem 
independent of its histone methyltransferase activity, as depletion of MLL has no 
effect on global H3K4 methylation on condensed chromosomes, although MLL-
deficient cells exhibit a delay in the resumption of transcriptional activity (Blobel et 





1.3 Current understanding of Mixed Lineage Leukemia 5 
1.3.1 The identification of Mixed Lineage Leukemia 5 
Aberrations in chromosome 7, either due to monosomy or partial deletion of 7q, are 
commonly associated with myeloid malignancies including myelodyplastic syndrome, 
acute myeloid leukemia (AML) and therapy-induced myeloid neoplasms (Brezinova 
et al., 2007; Hasle et al., 1999). Cytogenetic studies have delineated 7q22 as a critical 
region in myeloid malignancies (Johnson et al., 1996; Le Beau et al., 1996; Luna-
Fineman et al., 1995). A search for a candidate tumor suppressor gene within this 
region led to the identification of MLL5 (Emerling et al., 2002). MLL5 is found 
ubiquitously expressed on RNA tissue arrays, with highest levels found in fetal 
thymus, kidney and in adult hematopoietic tissues. No mutation or translocation of 
MLL5 has yet been detected in samples from leukemia patients (Emerling et al., 
2002). Interestingly, AML patients with high MLL5 expression are associated with 
high overall survival and relapse-free survival, demonstrating of the prognostic 
importance and the therapeutic potential of MLL5 in AML (Damm et al., 2011). 
 
1.3.2 Mixed Lineage Leukemia 5 in adult hematopoiesis 
Studies on Mll5 knockout mice have revealed that MLL5 might not be essential for 
embryonic development, but it plays a critical role in adult hematopoiesis (Liu et al., 
2009). MLL5 deficiency in mice results in impaired function of the long-term 
hematopoietic stem cells (Zhang et al., 2009). MLL5
-/-
 mice have reduced thymus, 
spleen and lymph nodes, suggesting of a role of MLL5 in lymphopoiesis, which was 
further confirmed by competitive reconstitution studies (Madan et al., 2009). In 
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addition, an increased incidence of eye infection in MLL5
-/-
 mice was observed due to 
defects in the maturation of neutrophiles (Heuser et al., 2009). Although Mll5 
knockout mice do not have an increased incidence of tumors, they suffer from mild 
growth retardation, male infertility and compromised immunity. Nonetheless, the 
physiological function of MLL5 and its cellular targets remain elusive. 
   
1.3.3 Mixed Lineage Leukemia 5 in epigenetic control 
Compared with MLL, MLL5 is more distantly related to the MLL family protein 
(Figure 1-5). MLL5 contains only one PHD zinc finger and its SET domain is located 
at the amino-terminal region rather than at the carboxyl-terminus. Whether MLL5 
possesses the histone lysine methyltransferase activity is still highly debatable. 
Several reports suggested that MLL5 lacks such intrinsic methyltransferase activity 
(Madan et al., 2009; Sebastian et al., 2009). However, a short isoform of MLL5 that 
contains both the PHD and SET domain was recently identified in a multisubunit 
complex in association with nuclear retinoic acid receptor, in which the isoform acts 
as a mono- and dimethyltransferase to H3K4 when the SET domain is glycosylated 
(Fujiki et al., 2009). In addition, Sebastian et al. reported that MLL5 indirectly 
regulates H3K4 methylation, represses cyclin A2 expression, and promotes myogenic 
differentiation through a hierarchy of chromatin and transcriptional regulators 
(Sebastian et al., 2009). Recently, a novel isoform of MLL5, which is present 
exclusively in HPV16/18-positive cells including human primary cervical carcinoma 
specimens and functions as a specific transcriptional regulator of E6 and E7, was 
identified by my colleague (Yew et al., 2011). Although how the MLL5 isoform 
derives from cervical carcinoma is not known, the study demonstrates the critical role 
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of MLL5 isoform in transcriptional regulation and reactivation of the cell cycle 
checkpoints. Collectively, these data suggest that MLL5 may play an integral role in 
chromatin regulation; however, the epigenetic regulatory mechanism is largely 
unexplored. 
 
1.3.4 Mixed Lineage Leukemia 5 in cell cycle regulation 
MLL5 was demonstrated as a nuclear protein and over-expression of MLL5 causes 
cell cycle arrest at G1 phase (Deng et al., 2004). Subsequently, the cell cycle 
regulatory function of MLL5 was further examined by RNAi-mediated loss-of-
function studies in mammalian cells. Surprisingly, MLL5-depleted cells exhibited 
both a G1 and a G2/M phase arrest, possibly through the dephosphorylation of Rb and 
upregulation of p21 (Cheng et al., 2008). The involvement of MLL5 in S phase 
progression was reported in year 2009, in which knocking down of MLL5 delayed the 
entry of quiescent myoblasts into S phase, but the completion of S phase was hastened 
(Sebastian et al., 2009). These results imply that MLL5 may play different regulatory 
roles throughout the cell cycle.  
 
This thesis proposes to make a contribution to the current understandings on the 
molecular function of MLL5 in mitosis regulation. The project started with an 
examination of the cell cycle dependent expression of MLL5. The level of MLL5 is 
relatively constant throughout the cell cycle; however, upon entry into mitosis, MLL5 
is phosphorylated and delocalizes from condensed chromosomes in a Cdk1-dependent 
manner. In addition, perturbation on the phosphorylation modification of MLL5 
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impedes mitotic entry, suggesting that the phosphorylation of MLL5 by Cdk1 is 
required for mitotic progression (Liu et al., 2010). Throughout these studies it was 
noted that MLL5-depleted cells experienced defective cell division and form 
multinucleus cells, implying a role for MLL5 in maintaining mitotic fidelity. Further 
investigation reveals that MLL5 maintains stability of the chromosomal passenger 
complex (CPC) by functionally interacting with Borealin (Liu et al., 2012, under 
revision). Collectively, this study demonstrates that MLL5 plays a role in mitotic 
entry and contributes to genomic integrity by facilitating the spatial and temporal 




CHAPTER 2 - MATERIALS AND METHODS 
2.1 Cell lines, culture condition and synchronization 
Human cervical carcinoma HeLa, osteosarcoma U2OS, colorectal carcinoma HCT116, 
human embryonic kidney HEK 293T, and human lung fibroblast WI-38 cells were 
cultured in Dulbecco’s modified Eagle’s medium (DMEM, Sigma-Aldrich, D1152) 
supplemented with 10% fetal bovine serum, 100 units/ml penicillin/streptomycin, and 
2 mM L-glutamine at 37 °C with 5% CO2 (hereafter referred to as complete medium). 
HeLa cells were synchronized to G2/M phase by blocking with 2 mM thymidine 
(Sigma-Aldrich, T1895) for 18 h, released in complete medium for 4 h, and then 
incubated in 100 ng/ml nocodazole (Sigma-Aldrich, M1404) for 12 h. For G1/S phase 
synchronization, HeLa cells were incubated with thymidine for 18 h, released in 
complete medium for 9 h, and again incubated with 2 mM thymidine for 18 h. The 
HEK 293T and HCT116 cells were synchronized to G2/M by incubation with 100 
ng/ml nocodazole, 10µg/ml taxol (Sigma-Aldrich, T7402), or 10µg/ml vinblastine 
(Sigma-Aldrich, V1377) for 16 h. G2 phase synchronization for HeLa and HEK 293T 
cells was achieved by incubation with 10 µM RO-3306 (Calbiochem, 217699) for 16 
h. U2OS cells were synchronized to G1 phase by double thymidine block. S phase 
U2OS cells were obtained by 4 h release from G1 arrest. G2 and M phase cells were 
arrested by incubation with 10 µM RO-3306 and 100ng/ml nocodazole for 16 h 
respectively. Metaphase arrest for U2OS cells was achieved by releasing from 




2.2 Plasmid construction and transfection 
MLL5 deletion mutants were generated by flanking each PCR fragment of MLL5 
cDNA with the FLAG sequence (Nucleotide sequence: ATGGACTACAAAGACG 
ATGACGACAAG; Amino Acid sequence: MDYKDDDDK) and cloning the 
fragments into the pEF6/V5-His vector (Invitrogen, K9610-20) in-frame with BamH I 
and XbaI sites. All the primers used for cloning were listed in Table 1. 
 
Figure 2-1. Schematic diagram shows all the fragments of MLL5 cloned into 
pEF6/V5-His vector. The N-terminal of these fragments was tagged with FLAG. The 
corresponding amino acid residue position was shown beside the construct. 
  
The CD-4 domain of MLL5 was cloned into the pEGFP-C1 vector  (Clontech, 6085-1) 
for GFP fusion protein expression (the GFP was fused to the N-terminal of the CD-4 
domain) in HEK 293T cells and cloned into pGEX-4T3 vector (Amersham 
Biosciences, 27-4583-01) for the GST fusion recombinant protein expression (the 
GST was fused to the N-terminal of the CD-4 domain) in the Escherichia coli 
BL21(DE3) strain.  
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Full length Borealin (NCBI Reference Sequence: NM_018101.2) and its deletion 
mutants (Borealin-N: aa1-120; Borealin-C: aa121-280) were amplified by PCR from 
the cDNA extracted from U2OS cells. The PCR was carried out using QIAGEN Taq 
PCR Core Kit (QIAGEN, 201223). The amplified PCR products were digested with 
Hind III and Not I restriction enzymes, and ligated into pXJ-40-HA vector (Manser et 
al., 1997). Primers used for cloning were listed in Table 1.  
  
A mammalian expression vector carrying mcherry gene sequence upstream of the 
multiple cloning sites is generated in-house. The mcherry sequence was cloned into 
pcDNA3.1 (Invitrogen, V790-20) in frame with the Hind III and BamH I sites without 
stop codon for subsequent mcherry-fusion protein expression. The primers were listed 
in Table 1 and the multiple cloning sites sequence of the new vector designated 
pcDNA3.1mcherry was illustrated in Figure 2-2. 
 
Human histone H2B cDNA sequence (NCBI Reference Sequence: NM_003526.2) 
was amplified by PCR from the cDNA extracted from U2OS cells. The PCR was 
carried out using QIAGEN Taq PCR Core Kit (QIAGEN, 201223). The amplified 
PCR products were digested with BamH I and Not I restriction enzymes, and ligated 
into pcDNA3.1mcherry vector. Primers were listed in Table 1.  
 
The pcDNA-mcherry-H2B Plasmid was transfected into U2OS cells by calcium 
phosphate method, and stable clones expressing H2B-mcherry were selected by 400 
µg/ml neomycin. The transfection was done in one 60-mm culture dish. Five micro 
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gram of pcDNA-mcherry-H2B Plasmid was diluted in water to make 180 µl solution 
in 1.5 ml microcentrifuge tube. 20 µl of CaCl2 (2.5 M) was added to the diluted DNA 
and mix well by pipetting. The DNA-Ca solution was then added drop-wisely into 
200 µl of 2xHBS solution (280 mM NaCl, 10 mM KCl, 1.5 mM Na2HPO4, 12 mM 
Glucose, 50 mM HEPES, pH7.05) and mixed well by gentle pipetting. The precipitate 
was incubated at room temperature for 20 min and added to the culture dish drop-
wisely. Eight hours after the transfection, medium was replaced with fresh complete 
medium containing 400 µg/ml neomycin. Two days later, the successfully transfected 
cells were trypsinized and replated into 6 x 60 mm plates and the selection was 
continued for another two weeks until the size of the colonies were big enough for 
transferring to 48-well culture dish. Clones with positive mcherry-H2B were screened 
under fluorescence microscope and amplified for live-cell imaging study.  
 
Plasmid transfection was also performed using the TransIT-LT1 (Mirus, MIR2300). 
For one 60-mm culture dish, 9 µl of the transfection reagent was diluted in 200 µl of 
serum free DMEM, mixed well by gently shaking the tube. 3 µg of plasmid DNA 
(100 ng/µl) was then added to the mixture and mixed well by gently shaking the tube. 
The DNA-TransIT complex was incubated at room temperature for 15 min and 
subsequently added to the culture drop-wisely. Transfection was performed using the 
TransIT-LT1 reagent for experiments in Chapter 3 of the thesis, and transfection was 





Figure 2-2. Illustration of pcDNA3.1-mcherry vector. The mcherry sequence was 
cloned by the Hind III and BamH I sites. There was no stop codon after the mcherry 
sequence for mcherry-fusion protein expression. The multiple cloning sites were 
listed. The sequencing primer for mcherry-fusion protein expression was listed in 
Table 1. 
 
2.3 Site-directed mutagenesis 
The FLAG-MLL5-T912A and FLAG-MLL5-CD4-T912A constructs were obtained 
by site-directed mutagenesis. Two complementary oligonucleotides containing Thr to 
Ala mutation at amino acid position 912 were synthesized, and the sequence was 
listed in Table 1. The PCR reaction was prepared by adding 5 µl of 10x reaction 
buffer, 100 ng of FLAG-MLL5 or FLAG-MLL5-CD4 plasmid, 125 ng of forward and 
reverse primers, 1µl of dNTP mix (10 mM), 1 µl of Pfu DNA polymerase (2.5 U/µl) 
(Stratagene, 600250) and variable amount of water to a final volume of 50 µl. The 
PCR reaction was run using the following parameters: 30 sec at 95 ⁰C for 1 cycle, 30 
sec at 95 ⁰C, 1 min at 55 ⁰C and 2 min/kb of plasmid length at 68 ⁰C for 18 cycles. 
Following the PCR reaction, the parental plasmid was digested by adding 1 µl of the 
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Dpn I restriction enzyme (20 U/µl) (New England BioLabs, R0176) and incubated at 
37 ⁰C for 2 h. 5 µl of the Dpn I treated DNA was transformed into competent DH5α, 
and colonies were amplified and plasmids containing the desired mutation were 




Table 1: Primers used for cloning* 
Primers used for the cloning of MLL5 fragments 
Construct  ID Primer Name Sequence (5’-3’) 
PHDSET 5’FLAG (5425) CGCGGATCCAATGGACTACAAAGACGATGACGACAAGAGCATAGTGATCCCA 
XbaI_mll5_PHDSET.rev GCTCTAGATTATGATTCCATTTCTACTTCATTAC 
Central domain BamHI_FLAGmll51683.for GCGGATCCATGGACTACAAAGACGATGACGACAAGGAATCAGAGGAGCAGATTG 
XbaI_mll5_3450.rev GCTCTAGATTAATTCTGGGGTGTGCAATTCCC 
C-terminal domain BHI_FLAGM53337.for  GCGGATCCATGGACTACAAAGACGATGACGACAAGAGAGGCATGTTTATGGAAACA 
XbaI_mll5.rev GCTCTAGATTAATGCCACCCTGACCCATGGTA 
Central domain-1 FLAGM5_1683.for GCGGATCCATGGACTACAAAGACGATGACGACAAGGAATCAGAGGAGCAGATTG 
XbaI2160.rev GCTCTAGATTAAAGTGCTGGAACTTCAGTTTC 
Central domain-2 FLAGM5_1683.for GCGGATCCATGGACTACAAAGACGATGACGACAAGGAATCAGAGGAGCAGATTG 
XbaI2472.rev GCTCTAGATTACAGAGCTTGTTTCAACCATCGC 
Central domain-3 BHIFLAGM5_2452.for GCGGATCCATGGACTACAAAGACGATGACGACAAGCGATGGTTGAAACAAGCTCTG 
XbaI_2817.rev GCTCTAGATTAAGGAGTTACTGGGGTAACTGG 
 
Central domain-4 BHIFLAGM5_2452.for GCGGATCCATGGACTACAAAGACGATGACGACAAGCGATGGTTGAAACAAGCTCTG 
XbaI_3450.rev GCTCTAGATTAATTCTGGGGTGTGCAATTCCC 
Central domain-5 BHIFLAGM5_2818.for GCGGATCCATGGACTACAAAGACGATGACGACAAGGGTACACCAGGAAATACCATG 
XbaI_3450.rev GCTCTAGATTAATTCTGGGGTGTGCAATTCCC 




Central domain-7 BHI_FLAGM52632.for GCGGATCCATGGACTACAAAGACGATGACGACAAG CAGTTGCTAGATTCGGTTTAC 
XbaI_M5_3180.rev GCTCTAGACTCCGTCCAGAGTGAGTCGAGTC 
Central domain-8 BHI_FLAGM5_2698.for GCGGATCCATGGACTACAAAGACGATGACGACAAGCACACCGATATTACTCCTATGG 
XbaI_M5_3180.rev GCTCTAGACTCCGTCCAGAGTGAGTCGAGTC 
Central domain-9 BHI_FLAGM52755.for GCGGATCCATGGACTACAAAGACGATGACGACAAG GATGATGAAACTTGTAGAAATGG 
XbaI_M5_3180.rev GCTCTAGACTCCGTCCAGAGTGAGTCGAGTC 
Primers used for the cloning of Borealin 
Construct  ID Primer Name Sequence (5’-3’) 
Borealin BorealinHindIII.for CCCAAGCTTATGGCTCCTAGGAAGGGCAGTAG 
BorealinNotI.rev TTTTCCTTTTGCGGCCGCTCATTTGTGGGTCCGTATGCTGC 
Borealin-N BorealinHindIII.for CCCAAGCTTATGGCTCCTAGGAAGGGCAGTAG 
Borealin120NotI.rev TTTTCCTTTTGCGGCCGCTCAATCTACCTGTATTACCTTTCG 
Borealin-C Borealin121HindIII.for CCCAAGCTTGAAATGATAGTGGAAGAGGAAG 
BorealinNotI.rev TTTTCCTTTTGCGGCCGCTCAATCTACCTGTATTACCTTTCG 
Primers used for the cloning of human H2B-mcherry 
Construct  ID Primer Name Sequence (5’-3’) 
pcDNA3.1mcherry HindIIICherry.for CCCAAGCTTATGGTGAGCAAGGGCGAGGAG 
BamHICherry_nostop.rev CGGGATCCCTTGTACAGCTCGTCCATGCC 
Mcherry seq primer.for CGTGGAACAGTACGAACGC 
Mcherry-H2B BamHIH2BnoATG.for CGGGATCCCCAGAGCCAGCGAAGTCTGCTC 
NotIH2B.rev ATAAGAATGCGGCCGCTTAGCGCTGGTGTACTTGGTGACG 
Primers used for mutagenesis study 













2.4 RNA interference 
Depletion of target protein was achieved by transfection of small interfering RNAs 
using Lipofectamine RNAiMAX (Invitrogen, 13778-150) according to the 
manufacturer’s protocol. For one well of the 6-well plate, 5 x 105 cells were seeded 
one day before transfection in antibiotic-free DMEM. 1.5 µl of siRNA duplex (30 
pmol) was diluted in 250 µl of DMEM, meanwhile 5 µl of RNAiMAX was diluted in 
250 µl of DMEM. The diluted siRNA was mixed with diluted RNAiMAX and 
incubated at room temperature for 15 min, then the complex was added to cells drop-
wisely. The sequences of the negative control and gene-specific siRNAs used in the 
study were listed in Table 2. 
 
2.5 Total cell extract preparation 
For total cell extract preparation, cells were collected by trypsinization, washed twice 
with ice-cold PBS, and directly lysed in Laemmli sample buffer (62.5 mM Tris-HCl 
pH 6.8, 2.5% SDS, 10% glycerol, 0.01% bromophenol blue) with dithiothreitol (DTT, 
100 mM) in a concentration of 2 x 10
7
 cells/ml. The lysate was boiled at 100 °C for 3 
min and sonicated for 20 sec at 20% output power (Sonics VCX130, Newtown, CT, 
USA). For Western blotting, 20 µl of total cell extract (4 x 10
5
 cells) was loaded onto 





Table 2: siRNA sequences 
siRNA Sequence (5’- 3’) 
Scrambled siRNA sense UUC UCC GAA CGU GUC ACG UdTdT 
Scrambled siRNA anti-sense ACG UGA CAC GUU CGG AGA AdTdT 
MLL5 #3 sense 
(NM_018682.3; 5215 *)  
CAG CCC UCU GCA AAC UUU CAG AAU UdTdT 
MLL5 #3 anti-sense 
(NM_018682.3; 5215) 
AAU UCU GAA AGU UUG CAG AGG GCU GdTdT 
MLL5 #4 sense 
(NM_018682.3; 6807) 
GCA CUG GUU GGG CAU UUU AdTdT 
MLL5 #4 anti-sense 
(NM_018682.3; 6807) 
UAA AAC GCC CAA CCA GUG CdTdT 
Aurora B sense 
(NM_004217.2; 267) 
CGC GGC ACU UCA CAA UUG AdTdT 
Aurora B antisense 
(NM_004217.2; 267) 
UCA AUU GUG AAG UGC CGC GdTdT 
Survivin sense 
(NM_001168.2; 166) 
GGA CCA CCG CAU CUC UAC AdTdT 
Survivin antisense 
(NM_001168.2; 166) 
UGU AGA GAU GCG GUG GUC CdTdT 
INCENP sense 
(NM_020238.2; 3058) 
GGC UUG GCC AGG UGU AUA UdTdT 
INCENP antisense 
(NM_020238.2; 3058) 
AUA UAC ACC UGG CCA AGC CdTdT 
Borealin #1 sense 
(NM_018101.2; 1111) 
AGG UAG AGC UGU CUG UUC AdTdT 
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Borealin #1 antisense 
(NM_018101.2; 1111) 
UGA ACA GAC AGC UCU ACC UdTdT 
Borealin #2 sense 
(NM_018101.2; 370) 
CAG CUG ACC UGG AUA UCA CdTdT 
Borealin #2 antisense 
(NM_018101.2; 370) 
GUG AUA UCC AGG UCA GCU GdTdT 
 
* The first number denotes the NCBI reference sequence number; the second number 




2.6 Cell lysate preparation using mild lysis buffer 
Cells were harvested by trypsinization, washed twice with ice-cold PBS, and 
resuspended in mild lysis buffer supplemented with protease and phosphatase 
inhibitors [150 mM NaCl, 20 mM, Tris-HCl (pH 8.0), 1% Triton X-100, 2 mM 
phenylmethylsulfonyl fluoride, 2 µg/ml leupeptin, 2 µg/ml aprotinin, 1 µg/ml 
pepstatin A, 1 mM Na3VO4, and 5 mM NaF] in a concentration of 4x10
7
 cells/ml. The 
cell lysate was passed through a syringe attached with 21G needle for 10 times to 
shear the genomic DNA. The lysate was incubated on ice for 15 minutes before 
centrifugation at 13000 rpm for 15 minutes at 4 ⁰C. The supernatant was transferred 
to a new tube and frozen at -80 ⁰C. 
 
2.7 Immunoprecipitation and Western blotting 
Cells were lysed in mild lysis buffer and lysates were precleared by 10 µl of protein 
A/G-agarose beads (Santa Cruz Biotechnology, sc-2001, sc-2002) for 15 min on ice. 
For each IP reaction, 500 µl of precleared lysate was incubated with 2 µg of anti-
FLAG (Sigma-Aldrich, F3165) or 10 µg of anti-MLL5 antibodies ( in house produced 
rabbit polyclonal antibody, which recognizes the following peptide sequence: 
CVSLLEYRKRQREAR) at 4 °C for 2.5 h, followed by 1.5 h incubation with 10 µl of 
protein A/G-agarose beads (Santa Cruz Biotechnology, sc-2001, sc-2002) at 4 °C with 
constant end-to-end rotation. The immune complexes were washed three times with 
mild lysis buffer. Proteins bound to the beads were then eluted with 60 μl of 
LSB/DTT (4:1 ratio) and boiled at 100 ⁰C for 3 min. The beads were then centrifuged 
at 13000 g for 1 min to dissociate the bound proteins. The supernatant was transferred 
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to a new tube and kept at -20 ⁰C for further Western blotting analysis. Conditions for 
Western blotting were listed in Table 3 and Table 4.  
 
2.8 Phosphatase treatment 
Two million mitotic HeLa cells were lysed in 100 µl of mild lysis buffer with protease 
inhibitors [150 mM NaCl, 20 mM, Tris-HCl (pH 8.0), 1% Triton X-100, 2 mM 
phenylmethylsulfonyl fluoride, 2 µg/ml leupeptin, 2 µg/ml aprotinin, 1 µg/ml 
pepstatin A]. 20 µl of lysate was treated with 10 units of calf intestinal alkaline 
phosphatase (CIP, New England BioLabs, M0290S) in the presence or absence of 10 
mM Na3VO4 and 5 mM NaF. The reaction was performed at 37 °C for 30 min and 
terminated by adding equal volume of LSB/DTT. Samples were then boiled at 100 ⁰C 








(protein < 150 
KDa) 
Transfer Buffer 
(protein ≥ 150 
KDa) 
TBS 
25 mM Tris base 
192 mM glycine 
0.1% SDS 
25 mM Tris base 
192 mM glycine 
20% (v/v) methanol 
25 mM Tris base 
192 mM glycine 
20% (v/v) methanol 
0.05% SDS 
20 mM Tris, 
500 mM NaCl, 
2.5 mM KCl 
(adjust to pH7.5 with 
HCl) 
 
















5% skim milk 
in TBS 
50 ⁰C for 30 
min, followed 
by blocking at 
RT for 2 h 
5% skim 




5% skim milk 
in TBS 
2 h incubation 
at RT 
TBS/0.05% Triton X-100 
Wash for 1 h with change 
of buffer in every 5 min 
MPM2 
5% skim milk 
in TBS 
RT incubation 
for 2 h 
5% skim 




5% skim milk 
in TBS 
2 h incubation 
at RT 
Wash with H2O for 3 
times, followed by 5 min 




5% skim milk 
in TBS 
RT incubation 
for 2 h 
5% skim 




5% skim milk 
in TBS 
2 h incubation 
at RT 
TBS/0.05% Tween-20 
Wash for 30 min with 






2.9 GST protein expression and purification 
Expression of GST-CD-4 was induced when the optical density at 600 nm (OD600) of 
the bacterial culture reached 0.5 with 0.1 mM isopropyl 1-thio-β-D-galactopyranoside 
(IPTG) in E. coli (BL21) at 30 °C for 3 h with constant shaking at 200 rpm. 
Expression of GST-Borealin was induced when OD600 of the bacterial culture reached 
1.0 with 0.5 mM IPTG in E. coli (BL21) at 18 °C for 16 h with constant shaking at 
200 rpm. 
 
After induction, 50 ml of bacterial culture was collected and lysed in 10 ml of lysis 
buffer (100 mM NaCl, 50 mM Tris, 1% Triton-X 100, pH 8.0) supplemented with 
protease inhibitor cocktail (Sigma-Aldrich, P8465).  The lysate was sonicated on ice 
for 5 min, and centrifuged at 13000 g for 15 min at 4 °C. The supernatant was 
incubated with 1 ml of glutathione S-Sepharose beads (Amersham Biosciences, 17-
0756-01) with constant rotation at 4 °C for 2 h. The beads were washed with 10 ml of 
ice-cold lysis buffer twice to remove non-specific binding proteins, and the GST-
protein beads were stored at 4 °C for further studies. 
 
2.10 In vitro kinase assay   
The in vitro kinase assay was conducted at 30 °C for 30 min in 20 µl reaction volume. 
The kinase reaction mixture contained 50 mM Tris (pH 7.5), 10mM MgCl2, 0.1mM 
EDTA, 2mM DTT, 0.1 mM ATP, 1 mM Na3VO4, 10 mM β-glycerol phosphate, 10 
µCi of [
32
P]ATP (PerkinElmer Life Sciences, NEG520A250UC), 10 units of active 
cyclin B1/Cdk1 complex (Promega, V2891), and 4 µg of GST or GST-CD-4. Histone 
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H1 (Sigma-Aldrich, H5505) was used as a positive control. The kinase reaction was 
terminated by adding equal volume of LSB/DTT. Samples were then boiled at 100 ⁰C 
for 3 min, and resolved on 12% SDS-PAGE and visualized by autoradiography. 
 
2.11 In vitro transcription/translation assay and binding assay 
The in vitro transcription/translation experiment was performed using the TnT
®
Quick 
coupled transcription/translation systems (Promega, L1170). 2µg of pEF6-
FLAGMLL5-PS, CD or CT plasmid DNA was incubated with 40 µl of the TnT
®
T7 
quick master mix, 1 µl of methionine and variable amount of nuclease-free water to a 
final volume of 50 µl. The reaction was incubated at 30 °C for 90 min. After 
incubation, 5 µl of the synthesized protein was kept as input, 20 µl of the protein was 
incubated with GST-beads, and 20 µl of the protein was incubated with GST-Borealin 
beads on ice for 2 h with occasional mixing. The protein-beads complex was washed 
with ice-cold mild lysis buffer for three times, eluted with 30 µl of LSB/DTT, boiled 
at 100 °C for 3 min, and transferred to a new tube for Western blotting analysis.    
 
2.12 Subcellular protein fractionation 
HeLa cells were washed twice with ice-cold PBS before being resuspended in 
cytosolic buffer [20mM HEPES (pH 7.9), 10mM KCl, 1.5 mM MgCl2, 340 mM 
sucrose, 10% glycerol, 0.1% Triton X-100, 1 mM DTT, 2 mM phenylmethylsulfonyl 
fluoride, 2 µg/ml leupeptin, 2 µg/ml aprotinin, 1 µg/ml pepstatin A, 1 mM Na3VO4, 
and 5 mM NaF] to a final concentration of 4 x 10
7
 cells/ml. After 5 min incubation on 
ice, the cell suspension was centrifuged at 1300 g at 4 °C for 5 min. The supernatant 
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was transferred to a new tube and saved as cytosolic protein fraction. The pellet was 
washed twice with cytosolic buffer and then lysed in nuclear lysis buffer (3 mM 
EDTA, 0.2 mM EGTA, 1 mM DTT, 2 mM phenylmethylsulfonyl fluoride, 2 µg/ml 
leupeptin, 2 µg/ml aprotinin, 1 µg/ml pepstatin A, 1 mM Na3VO4, and 5 mM NaF). 
The lysis reaction was incubated on ice for 20 min and then centrifuged at 1700 g at 
4 °C for 5 min. The supernatant was transferred to a fresh tube and kept as nuclear 
protein fraction. The final pellet was washed twice with nuclear lysis buffer, 
resuspended in LSB/DTT, sonicated, and kept as the chromatin-associated protein 
fraction. 
 
2.13 Cell cycle analysis 
One million cells were harvested by trypsinization, washed once with ice-cold PBS. 
The cell pellet was resuspended in 0.5 ml of PBS and added to 4.5 ml of ice-cold 70% 
ethanol drop-wisely. Ethanol-fixed cells were preserved on ice for at least two hours. 
Prior to analysis, cells were washed once in PBS, then resuspended and incubated in 
0.5 ml of Propidium Iodide (PI) staining solution [20 µg/ml propidium iodide (Sigma-
Aldrich, P4170), 100 µg/ml RNase A (Sigma-Aldrich, R6513), and 0.1% Triton X-
100] at 37 °C for 30 min.  
 
For double staining with anti-phosphohistone H3 Ser10 and PI, the ethanol fixed cells 
were rehydrated in PBS for 5 min, and blocked in 5 % BSA/PBS at room temperature 
for 30 min. Cells were subsequently incubated with 2 µg/ml anti-phosphohistone H3 
(Santa Cruz Biotechnology, sc-8656-R) in 5% BSA/PBS at room temperature for 1 h. 
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Cells were washed twice with ice-cold PBS/0.05% Tween-20 and incubated with 
secondary antibody (Alexa Fluor® 488 chicken anti-rabbit, Invitrogen, A11008) in 5% 
BSA/PBS at room temperature for 1 h. The cell pellet was washed twice with ice-cold 
PBS/0.05% Tween-20, and resuspended in PI staining solution as described above. 
 
Cell cycle progression was analyzed by Epics Altra flow cytometer (Beckman 
Coulter), and the data were analyzed using ModFit LTTM. Alternatively, cell cycle 
progression was analyzed by Dako Cytomation and data were analyzed using Summit 
software version 4.3 depending on the machine availability. 
   
2.14 RNA extraction and quantitative real-time reverse-transcription PCR 
(qRT-PCR) 
Total RNA was extracted using TRIzol reagent (Invitrogen, 15596) following 
manufacturer’s instructions. In brief, about 3 million cells were collected by 
centrifugation at 500 x g for 3 min. Cell pellet was then homogenized in 1 ml TRIzol 
reagent for 5 min at room temperature. Chloroform (0.2 ml) was added and mixed 
vigorously for 15 sec. After incubation for 3 min at room temperature and 
centrifugation at 12,000 x g for 15 min at 4 °C, the aqueous phase was transferred to a 
new RNase-free eppendorf tube. RNA was precipitated by addition of 0.5 ml 
isopropanol and collected by centrifugation at 12,000 x g for 10 min at 4 °C. The 
RNA pellet was then washed twice with 75% ethanol, air-dried, and dissolved in 
nuclease-free H2O. The RNA concentration was determined by measurement of 





 One-Step RT-PCR Kit with SYBR
®
Green (Bio-Rad, 1708893) 
following the instruction manual. For each reaction, 100ng total RNA, 1.5 µl of 
primer (forward and reverse), 1 µl iScript Reverse Transcriptase and nuclease-free 
H2O (variable amount) were mixed with 25 µl of the 2xSYBR Green Reaction Mix 
and resuspended well to get 50 µl of 1x reaction mix. The reaction mix was aliquoted 
into 3 tubes and incubated in a real-time thermal detection system (Bio-Rad) as 
follows: cDNA synthesis at 50 ⁰C for 10 min, iScript Reverse transcriptase 
inactivation at 95 ⁰C for 5 min, PCR cycling and detection for 45 cycles (10 sec at 95 
⁰C, 30 sec at 55 ⁰C) and melt curve analysis [1 min at 95 ⁰C, 1 min at 55 ⁰C and 10 
sec at 55 ⁰C (80 cycles, increasing each by 0.5 ⁰C each cycle)].  The mRNA 
abundance of the Aurora B, Survivin, INCENP, Borealin and MLL5 in MLL5-
depleted cells was normalized to the mRNA abundance of these genes in NC-siRNA 
control cells. RPL13A was used as an internal control. The sequences of primers used 




Table 5: Primers used for real-time RT-PCR 
Gene ID Sequence (5’- 3’) 
MLL5.for GCCACGCCTCCACGGATAAAATCG 
MLL5 .rev GGGGTGATACACTAATGAGTGG 
Aurora B.for CAGTGGGACACCCGACATC 
Aurora B.rev CTTCTCCCGAGCCAAGTACAC 
Survivin.for GGACCACCGCATCTCTACAT 









2.15 Immunofluorescence staining 
Cells were fixed with methanol at -20 ⁰C for 10 min or fixed with 4% paraformaldehe 
(PFA) in PBS at room temperature for 10 min. Fixed cells were rehydrated with PBS 
at room temperature for 10 min and permeablized with 0.5% Triton X-100 in PBS at 
room temperature for 5 min. Samples were blocked in 5% bovine serum albumin 
(BSA, Sigma-Aldrich, A7906) in PBS at room temperature for 2 h and subsequently 
incubated with primary antibodies at 4 ⁰C overnight. Cover slips were washed with 
PBS/0.05% Tween-20 for 3 times and incubated with secondary antibodies for 1 h. 
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The unbound secondary antibodies were washed off by PBS/0.05% Tween-20 for 3 
times, and cellular DNA was counterstained with 0.5 µg/ml of 4, 6-diamidino-2-
phenylindole, dihydrochloride (DAPI, Invitrogen, D1306) at room temperature for 5 
min. The coverslips were mounted with FluorSave reagent (Merck, 345789) to 
preserve the fluorescence signal. Images were acquired using inverted fluorescence 
microscope (Olympus) equipped with a cooled charge-coupled device camera 
(QImaging), using a x100 NA 1.4 objective and analyzed using Image-Pro Plus 
software (MediaCybernetics). 
 
2.16 Mitotic index determination 
HEK 293T cells were grown on polylysine-coated coverslips and transfected with 
MLL5 siRNA #4 for 24 h, followed by overexpression of FLAG-MLL5, FLAG-
MLL5∆CD-4, and FLAG-MLL5-T912A for 8 h. Transfected cells were synchronized 
to G2 phase by incubating with 10 µM RO-3306 for 16 h. G2 arrest cells were released 
for mitotic entry by washing out the RO-3306 and re-incubated with complete 
medium containing 100 ng/ml nocodazole. At 0, 20, 50, and 90 min post-release, 
coverslips were fixed with methanol and stained for phosphohistoe H3Ser10 antibody. 
Mitotic index was assessed by calculating the percentage of phosphohistone H3Ser10-







2.17 Fluorescence in situ hybridization 
Fluorescence in situ hybridization (FISH) was performed according to the 
manufacture’s protocol. Two million cells were harvested by trypsinization, 
resuspended in 2 ml of hypotonic solution (0.075M KCl) and incubated at room 
temperature for 15 min. Cells were prefixed by adding 2 drops of methanol/acetic acid 
fixative (3:1 vol/vol) and centrifuged at 250 g for 5 min. The cell pellet was 
resuspended in 5 ml of fixative and centrifuged again. The final pellet was 
resuspended in 100 µl of fixative and dropped onto clean glass microscope slide and 
allowed the slide to fully dry by evaporation. For each sample, 3 µl of probe for 
chromosome 8 and 3 µl of probe for chromosome 12 were added (CytoCell, LPE08 
and LPE12). The sample was denatured at 75 ⁰C for 2 min, followed by incubation at 
37 ⁰C overnight. Non-specific bound probes were washed off by sequentially 
incubating the slide in 0.25 x SSC at 72 ⁰C for 2 min, and in 2 x SSC/0.05 % Tween 
20 at room temperature for 30 sec. DNA was counter stained with DAPI, and slide 
was viewed under fluorescence microscope (Olympus) equipped with a cooled 
charge-coupled device camera (QImaging), using a x100 NA 1.4 objective.  
 
2.18 Cold-induced microtubule depolymerization assay 
U2OS cells were transfected with NC- or MLL5-siRNA for 24 h and synchronized to 
M phase by incubating with 100 ng/ml nocodazole for additional 14 h. Mitotic cells 
were released onto sterile coverslips contained in 35-mm culture dishes and incubated 
with fresh medium containing 20µM MG132 for 1.5 h. Before fixation, medium was 
aspirated from culture dish, and replaced with complete media containing 20µM 
MG132 which was precooled to 4°C. The culture dishes were placed in a shallow ice 
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bath for 10 min to depolymerize microtubules which were not bound to kinetochores. 
After the incubation immunofluorescence was performed as described in section 2.14. 
  
2.19 Monastrol wash-out experiment 
U2OS cells were seeded onto sterile coverslips contained in 35-mm culture dishes to 
about 30% confluence one day before siRNA transfection. Twenty four hours after 
transfection, cells were treated with 10µM Monastrol (Sigma-Aldrich, M8515) for 
additional 14 h. NC- or MLL5-depleted U2OS cells were released from monastrol and 
allowed to achieve chromosome alignment for a total of 60 min in the presence of 10 
µM MG132. Coverslips were fixed in methanol every 20 min to examine the 
efficiency of correcting the chromosome mis-alignment. Immunofluorescence 
staining for α-tubulin antibody and CREST was performed as described in section 
2.15. 
 
2.20 Confocal microscopy 
The confocal microscope was operated by Olympus fluoview ver.1.7c software. For 
each cell, a stack of images with 0.46 µm step size in the z-direction was obtained. 
Images were analyzed using Image J software, and sister kinetochores were identified 
by their presence in the same plane of focus. A single line was drawn between the 
brightest pixels of each kinetochore pair and the length of the line was recorded. All 




2.21 Live-cell imaging 
Cells were cultured on glass-bottom 35-mm culture dish (World Precision Instruments) 
and assembled in a stage top incubator supplemented with 5% CO2. Sequences of 
images were acquired every 3 min for 3 h using a x20 NA 0.75 objective on the 
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Goat anti-mouse HRP 
conjugate 
1: 10000 (WB) GE Healthcare RPN2108 
Donkey anti-rabbit HRP-
conjugate 
1: 5000 (WB) Thermo Scientific 31458 
Alexa Fluor® 488 chicken 
anti-rabbit 
1:200 (IF)  Invitrogen A11008 
Alexa Fluor® 568 goat anti-
mouse 
1:200 (IF)  Invitrogen A11031 
Alexa Fluor® 594 goat anti-
human 
1:200 (IF)  Invitrogen A-11014 





TrueBlot® Anti-Rabbit Ig IP 
Beads 
10 µl/reaction eBioscience 00-8800-25 
TrueBlot® Anti-Mouse Ig IP 
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CHAPTER 3: RESULTS - Phosphorylation of Mixed Lineage 
Leukemia 5 by Cdk-1 Affects Its Cellular Distribution and Is 
Required for Mitotic Entry 
3.1 Introduction 
As described earlier, the MLL family protein has been demonstrated to play a role in 
cell cycle regulation. Our group intends to unravel the molecular mechanism of 
MLL5 in the cell cycle control. Initial characterization of MLL5 has shown that over-
expression of MLL5 inhibits the G1/S transition in HEK 293T cells (Deng et al., 
2004). In order to further define the role of MLL5, a siRNA-based loss-of-function 
approach was applied to study the effect of MLL5 knockdown. Interestingly, a dual-
phase arrest at both G1 and G2/M phases in MLL5-depleted cells was observed 
(Cheng et al., 2008). Since then, the MLL5 research in cell cycle regulation was 
channeled in two directions. My colleagues continued to investigate the mechanism of 
MLL5-knockdown-induced G1 arrest; while I pursued its role in G2/M transition and 
mitotic progression. 
 
3.2 MLL5 displays slower gel mobility at the G2/M phase boundary 
MLL5 forms intranuclear foci and both its up- and down-regulation inhibits cell cycle 
progression. To gain more insights into MLL5 in cell cycle control, the expression of 
MLL5 throughout the cell cycle was examined. HeLa cells were released from the 
G2/M boundary for 16.5 h, and the progression of the cell cycle was monitored by 
measuring the cellular DNA content. At each indicated time point, the whole cell 
lysate was prepared and analyzed by Western blotting using an anti-MLL5 polyclonal 
61 
 
antibody and cell cycle progression markers (Figure 3-1). MLL5 displayed slower gel 
mobility at the G2/M phase boundary (t=0 h, denoted by arrow head) but converted to 
a faster migrating form immediately after exit from mitosis (t=1.5 h, denoted by 
arrow). The large amount of cyclin B1 at 0 h indicated the successful synchronization 
of HeLa cells to G2/M phase, and its sudden degradation at 1.5 h indicated the exit 
from mitosis. The increase in cyclin A expression after release for 12 h suggested the 
entry into S phase. It was quite surprising that changes in gel mobility for MLL5 
could be detected by a denaturing polyacrylamide gel due to its large size (>200kDa), 
and such dramatic change in mobility indicated that MLL5 underwent some post-









Figure 3-1. MLL5 displays slower gel mobility at G2/M transition. Expression of 
MLL5 in HeLa cells released from the G2/M boundary. Total cell extract was 
prepared every 1.5 h after release from nocodazole. Cyclin A, cyclin B1 and phospho-
histone H3Ser10 serve as cell cycle progression markers. Actin serves as a protein 
loading control. Arrows indicate MLL5 and arrow heads denote the slower-migrating 




To ensure that the observed mobility change was not cell type-specific or due to drug 
treatment with nocodazole, HeLa, U2OS, or HCT116 cells were synchronized to the 
G2/M phase boundary with two other drugs, vinblastine and taxol. Vinblastine inhibits 
microtubule assembly by binding tubulin and inducing self-association in spiral 
aggregates, thus blocks the cell cycle at M phase. Taxol arrests cell cycle at M phase 
by binding to microtubules and inhibiting the microtubule dynamics. Consistently, a 
similar decrease in the electrophoretic mobility of MLL5 was detected in all three cell 
lines, implying that MLL5 indeed underwent certain post-translational modifications 




Figure 3-2. Expression of MLL5 in asynchronous (NT) and G2/M-arrested HeLa, 
U2OS and HCT116 cells. G2/M synchronization was achieved by treatment with 
nocodazole (Noc), vinblastine (Vin) or taxol (Tax). Mitotic cells were harvested by 
shaking-off method and total cell extract was prepared. Actin serves as a protein 
loading control. Arrows indicate MLL5 and arrow heads denote the slower-migrating 





In order to rule out the possibility that the observed decrease in gel migration of 
MLL5 may result from prolonged delay at G2/M phase by incubating with drugs, 
HeLa cells were synchronized to the G1/S phase boundary by a double thymidine 
block, and the expression of endogenous MLL5 protein was examined at each 
indicated time point after release. Cell cycle progression was again monitored by 
measuring the cellular DNA content (Figure 3-3A). The slower migrating form of 
MLL5 was detected between 10 and 11 h after release from the G1/S boundary, 
correlating with the increase in mitotic index (phosphorylation of histone H3Ser10) 
and the destruction of cyclin B1 (Figure 3-3B). Consistent with the observations made 
at release from the G2/M boundary, these data demonstrated that the post-translational 























Figure 3-3. Expression of MLL5 in HeLa cells that were released from G1/S 
synchronization. Cells were synchronized to G1/S boundary by double thymidine 
block, and were released into complete medium for cell cycle progression. A. cell 
cycle progression was monitored by PI staining and FACS analysis. B. Total cell 
lysate was prepared every hour post-release. Cyclin A, cyclin B1 and phosphohistone 
H3Ser10 serve as cell cycle progression markers. Actin serves as a protein loading 
control. Arrows indicate MLL5 and arrow heads denote the slower-migrating form of 
MLL5 at G2/M phase. 
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3.3 MLL5 is phosphorylated during mitosis 
Phosphorylation signaling is essential in the regulation of protein function, stability, 
localization, and protein-protein interactions. Mitosis-specific phosphorylation and 
de-phosphorylation have been extensively studied. To investigate whether the slower-
migrating form of MLL5 was due to phosphorylation, mitotic extract of HeLa cells 
was subjected to phosphatase treatment in the presence or absence of phosphatase 
inhibitors. As shown in Figure 3-4A, phosphatase treatment converted the slower-
migrating MLL5 in the mitotic extract to a faster-migrating form as observed in 
asynchronous cell extract. Moreover, this conversion was markedly blocked by 
phosphatase inhibitors, suggesting that the decreased gel mobility of MLL5 was likely 
due to phosphorylation. The observation was further confirmed by 
immunoprecipitation of the endogenous MLL5 from either asynchronous or mitotic 
HeLa cell lysates. A mitosis-specific phosphorylation signal was detected by anti-
phospho-Ser/Thr antibodies, but not anti-phospho-Tyr antibodies (Figure 3-4B). The 
same blot was re-probed with anti-MLL5 antibodies to ensure equal loading. However, 
the possibility of MLL5 being phosphorylated on tyrosine residues cannot be ruled 
out completely, since an undetectable phospho-Tyr signal might result from less 









Figure 3-4. MLL5 is phosphorylated at Ser/Thr residues at G2/M phase. A. 
Alkaline phosphatase treatment of G2/M-arrested HeLa cell extract converted MLL5 
to a faster-migrating form that ran to the same migrating position as in asynchronous 
cell extract. B. Endogenous MLL5 was immunoprecipitated from asynchronous or 
G2/M-arrested HeLa cell extracts. Phosphorylated MLL5 (arrow heads) is present at 





3.4 The central domain of MLL5 is phosphorylated at mitosis 
To identify which of the functional domain of MLL5 is responsible for mitosis-
dependent phosphorylation, three deletion mutants of MLL5, consisting of the PHD 
and SET domains (PS), the central domain (CD) or the C-terminal domain (CT), were 
constructed and N-terminally tagged with a FLAG epitope (Figure 3-5A). All these 
truncated domains contained at least one nuclear localization signal to ensure a correct 
nuclear expression.  Nocodazole was added into the culture medium 24 h post-
transfection for G2/M synchronization, followed by immunoprecipitation and Western 
blotting. Only the full-length MLL5 protein and the central domain were detectable 
by anti-phospho-Ser/Thr antibodies, and the phosphorylation modification was greatly 
increased in the presence of nocodazole (Figure 3-5B, left panel). To further delineate 
the target site of phosphorylation, the central domain was dissected into smaller 
fragments (Figure 3-5A). Subsequently, Western blotting revealed that the 
phosphorylation signal on the CD-4 domain (amino acid 818-1150) was greatly 
enriched upon nocodazole treatment (Figure 3-5B, right panel). There was no 
detectable phosphorylation signal for either CD-3 or CD-5 constructs, implying that 










Figure 3-5. The CD-4 domain of MLL5 is sufficient to mediate mitotic 
phosphorylation. A. Schematic representation of MLL5 and deletion fragments; PS: 
PHDSET domain, CD: central domain, CT: C-terminal domain. The central domain 
was further dissected into CD-1, CD-2, CD-3, CD-4 and CD-5. B. Full-length MLL5 
and various deletion mutants were immunoprecipitated from untreated or nocodazole-
synchronized HEK 293T cell lysates with anti-FLAG antibodies and detected by anti-
phospho-Ser/Thr or anti-FLAG antibodies. MLL5 is phosphorylated at Ser/Thr 
residues on the CD-4 domain at G2/M phase. The asterisk at 25 kDa denotes antibody 
light chains.  
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3.5 MLL5 is phosphorylated by Cdk1 in vitro 
Given that the cyclin B1/Cdk1 complex is the major component of the maturation 
promoting factor that drives the mitotic progression (Moseley and Nurse, 2009), 
whether phosphorylation of MLL5 was affected by the Cdk1 inhibitor roscovitine, or  
its activator okadaic acid was tested (Meijer et al., 1997; Yamashita et al., 1990). 
When mitotic HeLa cells were treated with increasing concentrations of roscovitine, a 
de-phosphorylated form of MLL5 was observed in a dose-dependent manner (Figure 
3-6A). This suggests that the inhibition of Cdk1 activity attenuates the 
phosphorylation of MLL5 during mitosis. Okadaic acid, a potent inhibitor of protein 
phosphatase 2A, is known to induce the activation of Cdk1 through the 
phosphorylation of Cdc25, leading to de-phosphorylation of Cdk1 at Tyr 15. Indeed, 
when asynchronous HeLa cells were treated with okadaic acid, an increase in MLL5 
phosphorylation was observed concomitantly with the activation of Cdk1, as indicated 
by the de-phosphorylation of Cdk1 at Tyr 15 (Figure 3-6B).  
 
Next, a GST pull-down assay was employed to examine the interactions, if any, 
between MLL5 and Cdk1. Purified GST-CD-4 glutathione sepharose beads were 
incubated with HeLa cell lysates, which were extracted after 8, 10 or 12 h release 
from G1/S boundary, corresponding to the early G2, G2 and G2/M phases, respectively. 
Results demonstrated that GST-CD-4, but not GST, can be co-purified with Cdk1 
only in the cell extract of the G2/M phase. The interactions diminished significantly 
when the extracts were depleted of Cdk1 by pre-clearing with anti-Cdk1 antibodies 
(Figure 3-7).  Collectively, these data suggested that Cdk1 may be a likely kinase for 
MLL5 mitotic phosphorylation. We then explore the possibility that the cyclin 
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B1/Cdk1 complex can phosphorylate GST-CD-4 domain in vitro. As shown in Figure 
3-8, cyclin B1/Cdk1 was able to specifically confer 
32
P to CD-4 and histone H1, but 
not to GST. This data demonstrates that the central region of MLL5 (CD-4 domain) is 







Figure 3-6. MLL5 is phosphorylated by Cdk1 at G2/M. A. Mitotic HeLa cells were 
treated with various concentrations of roscovitine for 4 h in the presence of 
nocodazole. The phosphorylation of MLL5 was inhibited by roscovitine in a dose-
dependent manner. B. Asynchronous HeLa cells were treated with various 
concentrations of okadaic acid for 4 h. The phosphorylation of MLL5 was gradually 







Figure 3-7. GST-CD-4 protein co-purified with Cdk1 in mitotic HeLa cells. 
Purified GST-CD-4 glutathione sepharose beads were incubated with HeLa cell 
lysates, which were extracted after 8, 10 or 12 h release from G1/S boundary, 
corresponding to the early G2, G2 and G2/M phases, respectively. GST-CD-4, but not 










Figure 3-8. The central region of MLL5 (CD-4 domain) is a substrate of the 
cyclin B1/Cdk1 complex.  Upper panel: GST-CD-4 was phosphorylated by human 
recombinant cyclin B1/Cdk1 complex in an in vitro kinase assay. Histone H1 and 
GST served as a positive and a negative control, respectively.  Lower panel: 





3.6 MLL5 is phosphorylated on threonine 912 
To gain information on the consequence of the phosphorylation modification by Cdk1, 
we proceed to determine the phosphorylation site on MLL5. The amino acid sequence 
of CD-4 domain was examined and twenty-one Ser/Thr-Pro motifs were found within 
this region. Among these Ser/Thr-Pro motifs, three of them fit to the Cdk1 consensus 
motif S/T-P-X-K/R (Figure 3-9A) (Moreno and Nurse, 1990). Based on the sequence 
analysis, MLL5 fragments which comprise sequential deletion of the putative Cdk1-
targetting sites were constructed (Figure 3-9A) and tested whether the mitotic 
phosphorylation of these fragments can be abolished. As shown in Figure 3-9B left 
panel, removal of Ser1070 (CD-6) or Thr869 (CD-7 and CD-8) did not affect the 
phosphorylation of MLL5 in mitotic cells; whereas deletion of Thr912 site (CD-9) 
completely eliminated the mitotic phosphorylation on MLL5. This result suggested 
that Thr912 residue is critical for the mitotic phosphorylation of MLL5. Next, site-
directed mutagenesis was carried out and the Thr912 residue on the CD-4 domain was 
replaced by alanine. Immunoprecipitation studies revealed that the CD-4-T912A was 
unable to be phosphorylated upon nocodazole treatment (Figure 3-9B, right panel).  
Taken together, these findings imply that the Thr912 residue of MLL5 is a targeting 









Figure 3-9. MLL5 is phosphorylated on threonine 912. A. Schematic 
representation of MLL5-CD-4 domain and its deletion fragments. The potential Cdk1 
targeting sites on MLL5-CD-4 domain are denoted based on the consensus motif for 
Cdk1 kinase (S/T-P-X-K/R).  B. left panel: The CD-4 domain and deletion mutants 
(CD-6, 7, 8 and 9) with sequential deletion of Cdk1 targeting sites were 
immunoprecipitated from nocodazole-synchronized extract of HEK 293T cells using 
anti-FLAG antibodies and detected by anti-phospho-Ser/Thr or anti-FLAG antibodies. 
The phosphorylation on MLL5 is abrogated when Thr912 residue was deleted. right 
panel: Mutation of Thr912 to Ala on the CD-4 domain eliminated the phosphorylation 




3.7 Dynamic changes in phosphorylation and subcellular localization of MLL5 
during mitosis 
To elucidate the functional significance of the phosphorylation modification of MLL5, 
a time course study to monitor MLL5 phosphorylation status during the late G2 phase 
to G2/M transition was carried out in synchronized HeLa cells. A specific and 
reversible Cdk1 inhibitor RO-3306 was used to synchronize HeLa cells to G2 phase 
(Vassilev et al., 2006). After release, mitotic progression was monitored by examining 
the DNA structure. The subcellular localization and the phosphorylation modification 
of MLL5 were analyzed by indirect immunofluorescence staining and Western 
blotting. As shown in Figure 3-10A, MLL5 formed nuclear speckles at the G2 phase 
(time 0). After 10 min release, chromatin started to compact and MLL5 speckles were 
dissolved. The disappearance of nuclear speckles coincided with the phosphorylation 
of MLL5 as shown by the retarded gel migration using Western blotting analysis 
(Figure 3-10B). When chromatin further condensed and nuclear envelop broke down, 
MLL5 was excluded from chromosomes, resulting in cytosolic localization. As 
mitosis progressed, MLL5 was kept in a phosphorylated state and delocalized from 
condensed chromosomes. Until the DNA in the daughter cells started to relax, MLL5 
was found to be dephosphorylated and re-localized to the nucleus at 90 min after 
release. Taken together, these data imply that the phosphorylation status of MLL5 












Figure 3-10. Phospho-MLL5 dissociates from mitotic chromosomes. HeLa cells 
were grown on cover-slips and G2-arrested cells were released into fresh medium. 
Samples for immunofluorescence staining and Western blotting were collected every 
10 min. A. The localization of MLL5 at each stage was examined by 
immunofluorescence staining (n=20 per sample). MLL5 formed intranuclear foci in 
G2 phase (Time 0), but it dissociated from condensed chromosomes and displayed 
cytosolic staining pattern during mitosis (10 min: prophase, 20 min: prometaphase, 30 
min: metaphase, 50 min: anaphase, 60 min: telophase). When cells completed mitosis 
(90 min), MLL5 re-localized to nucleus. Scale bar: 10 μm. B. Time course study on 
the phosphorylation of MLL5 during mitosis by Western blotting.  
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To further examine the correlation between the phosphorylation of MLL5 and its sub-
cellular localization, HeLa cells were synchronized to different cell-cycle stages and 
were fractionated into cytoplasmic (c), nucleoplasmic (n) and chromatin-associated 
(ch) fractions (Figure 3-11). In S and G2 phases, MLL5 mainly associated with 
chromatin. When G2-arrested cells were released for mitotic progression (15 min), 
approximately 50% of total cellular MLL5 was phosphorylated and the phospho-
MLL5 was seen in the cytosolic fraction. As in nocodazole-arrested mitotic cells, 
MLL5 was fully phosphorylated and excluded from chromosomes. These results 
confirmed that the phosphorylated MLL5 exhibits a distinct and dynamic sub-cellular 
localization during mitosis. 
 
To further substantiate the role of cyclin B1/Cdk1 in mediating the phosphorylation of 
MLL5, we questioned if inhibition of Cdk1 kinase activity could influence the 
phosphorylation and sub-cellular localization of MLL5 in mitosis. As shown in Figure 
3-12, when cells were arrested in mitosis, MLL5 was phosphorylated and dissociated 
from mitotic chromosomes. Meanwhile, Cdk1 was kept in an active state since 
phosphorylation on Cdk1 was undetectable with the anti-pY15-Cdk1 antibody (Figure 
3-12, left panel). However, when Cdk1 kinase activity was inhibited by RO-3306 in 
mitotic cells for 1.5 h (Figure 3-12, middle panel), the phosphorylated form of MLL5 
was not detected in the whole cell lysate and cytosolic fraction, suggesting that MLL5 
is de-phosphorylated upon inhibiting Cdk1 activity. Successful inhibition of Cdk1 
activity was denoted by the increase in phosphorylation of Cdk1 on Tyr15. The 
dephosphorylation of MLL5 was not due to mitotic exit as the RO-3306 treated 
mitotic cells remained at DNA content of 4N (Figure 3-12B). When cells were 
released from M phase, the G1 re-entered cells displayed a de-phosphorylated form of 
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MLL5 and re-associated with chromatin (Figure 3-12, right panel). Altogether, our 
data suggest that the phosphorylation and localization of MLL5 are highly dependent 








Figure 3-11. The correlation between the phosphorylation of MLL5 and its sub-cellular localization. HeLa cells were arrested at difference 
cell cycle stages, and cellular fractionation was performed. Cells arrested in S phase were collected after G1/S release for 4 h, G2 phase arrest 
was achieved by incubation with RO-3306 for 20 h and M phase cells were synchronized by Thy-nocodazole method. α-tutbulin and histone H3 
were employed as cytoplasmic (c) and chromatin-associated (ch) protein marker respectively, and nucleoplasmic protein was denoted as group 
(n). Whole cell lysate (wcl) serves as total cellular protein control. Phosphorylation and subcellular localization of MLL5 were examined by 




 panel), whereas in mitotic cells, MLL5 was 














Figure 3-12. The mitotic phosphorylation and localization of MLL5 were 
dependent on Cdk1 kinase activity. A. In mitosis-arrested HeLa cells, MLL5 was 
phosphorylated and extracted in the cytoplasmic fraction (Left panel). When mitotic 
HeLa cells were treated with RO-3306 for 1.5 h, MLL5 was dephosphorylated and 
extracted in the chromatin fraction. Inhibition of Cdk1 activity was revealed by the 
increase in phosphorylation of Cdk1 on Tyr15 (Middle panel).  When mitotic cells 
were released into complete medium for 1.5 h and re-entered into G1 phase, MLL5 
was dephosphorylated and associated with chromatin (Right panel). Phospho-MLL5 
was denoted by arrow head. B. The cell cycle profile of each sample was analyzed by 
PI staining and FACS analysis.  
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3.8 Phosphorylation modification of MLL5 and mitotic progression 
The above results demonstrate that the phosphorylation modification of MLL5 
regulates its cellular distribution. To further elucidate the functional consequences of 
MLL5 phosphorylation by Cdk1 on mitotic progression, the CD-4 domain that could 
be a competitive substrate of MLL5 for Cdk1 kinase was used in the following 
experiment. The GFP-fused CD-4 domain was expressed in HEK 293T cells in the 
presence of the G2-synchronizing drug RO-3306 for 20 h. Cells were then released in 
the presence or absence of nocodazole for 5 h, the population of GFP-CD-4 positive 
or GFP-negative cells were sorted separately before harvesting for Western blotting. 
As shown in Figure 3-13, when G2-arrested cells were released into the medium 
containing nocodazole, a slower-migrating phosphorylated form of MLL5 was 
detected in GFP-negative control cells but barely seen in GFP-CD-4 expressing cells; 
and a significant reduction in the phosphorylation of histone H3Ser10 was also 
observed in GFP-CD-4 expressing cells (Figure 3-13, lanes 3 and 4). These data 
indicate that over-expression of the CD-4 domain successfully blocked the 
phosphorylation of endogenous MLL5, and these cells encountered compromised 
mitotic entry. Notably, the failure in detecting the phospho-MLL5 in GFP-CD-4-
positive cells did not seem to be due to the loss of Cdk1 kinase activity, since no 
significant difference in the de-phosphorylation of Cdk1 at Tyr15 was observed 
between GFP-negative and GFP-CD-4 cells (Figure 3-13). We next asked if blocking 
the phosphorylation of endogenous MLL5 at the G2/M transition could affect mitotic 
progression. As shown in Figure 3-14, both the GFP-negative and GFP-CD-4 cells 
were successfully synchronized at G2 phase by RO-3306. However, when G2-
synchronized cells were released for 5 h, a total of 65.6% GFP-negative control cells 
was able to pass through mitosis and re-enter into the G1 phase of the next cell cycle. 
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In contrast, only 22.7% of GFP-CD-4 expressing cells were able to progress through 
mitosis and enter into G1 phase, indicating impeded or delayed mitotic progression 
(Figure 3-14, lower panel). Collectively, the data suggests that the phosphorylation of 




Figure 3-13. Inhibition of endogenous MLL5 phosphorylation impedes mitotic 
progression and arrests cells at the G2/M transition. HEK 293T cells were 
transfected with GFP-CD-4 in the absence (NT) or presence of RO-3306 for 20 h 
before release into complete medium or nocodazole-containing medium for 5 h. The 
population of GFP-CD-4 positive or GFP-negative cells released from RO-3306 was 
sorted separately before harvesting for Western blotting. Phosphorylation of 
endogenous MLL5 at G2/M phase (G2 release + Noc) was inhibited by ectopic over-









Figure 3-14. Inhibition of endogenous MLL5 phosphorylation impedes mitotic 
progression and arrests cells at the G2/M transition. HEK 293T cells were 
transfected with GFP-CD-4 in the absence (NT) or presence of RO-3306 for 20 h 
before release into complete medium or nocodazole-containing medium for 5 h. Cell 
cycle analysis for GFP-negative control cells and GFP-CD-4 expressing cells. The 
percentage represents the population that successfully progressed through mitosis and 




The above findings suggested that phosphorylation of MLL5 by Cdk1 might be a vital 
event associated with mitotic entry. This hypothesis prompted us to further investigate 
the causality between phosphorylation of MLL5 and mitotic progression. Studies on 
cell cycle progression have shown that depletion of MLL5 by siRNA caused G1 and 
G2 arrests (Cheng et al., 2008). Whether the phospho-domain deletion mutant (FLAG-
MLL5ΔCD-4) or FLAG-MLL5-T912A mutant could overcome the G2 arrest and 
compensate the cellular function from the loss of endogenous MLL5 was examined. 
To avoid the off-target effects, endogenous MLL5 was knocked down by two 
different siRNA duplexes targeting at either coding region (siRNA #3) or 3’ 
untranslated region (siRNA #4), which have been described previously (Cheng et al., 
2008). The rescue experiment was performed in the group of cells transfected with 
siRNA #4 because it was unable to affect the exogenously-overexpressed FLAG-
MLL5, FLAG-MLL5ΔCD-4 or FLAG-MLL5-T912A proteins. After 24 h of siRNA 
transfection, FLAG-MLL5, FLAG-MLL5ΔCD-4 or FLAG-MLL5-T912A was 
introduced for 8 h, followed by treating with RO-3306 for another 16 h. To study the 
mitotic entry, cells were released into nocodazole-containing medium to assess the 
cumulative mitotic index at each indicated time point. Meanwhile, the localization of 
FLAG-MLL5 and the mutants was determined by immunofluorescence staining. As 
presented in Figure 3-15, FLAG-MLL5 localized to the nuclei in G2-synchronized 
cells. After release from G2 phase, it dissociated from condensed mitotic 
chromosomes which were marked by anti-phospho-histone H3Ser10 antibody. In 
contrast, FLAG-MLL5ΔCD-4 and FLAG-MLL5-T912A were found to reside in 
nucleus in both G2 synchronized and released cells, and there was no phosphorylation 
on histone H3Ser10, suggesting that deficiency in phosphorylation restricted FLAG-
MLL5ΔCD-4 and FLAG-MLL5-T912A to the nucleus and impeded the mitotic entry.  
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Cumulative mitotic index was also recorded to quantify the rescue efficiency (Figure 
3-16). In scrambled-siRNA-transfected cells, the mitotic cells reached 78.3% after G2 
release; while in MLL5-knockdown cell, the percentage of G2 phase cells which could 
progress into mitosis was only 33-35%. If endogenous MLL5-depleted cells were 
transfected with the FLAG-MLL5 construct, the mitotic index was able to increase to 
62.8%. In contrast, mitotic entry rate for FLAG-MLL5ΔCD-4 and FLAG-MLL5-
T912A positive cells were only 26.4% and 32.1%, respectively. Knockdown 
efficiency of the endogenous MLL5 and the deficient phosphorylation of FLAG-
MLL5ΔCD-4 and FLAG-MLL5-T912A were revealed by immunoblots in Figure 3-
17. Collectively, these data demonstrated that the wild-type MLL5, but not the 








Figure 3-15. G2 arrest caused by the depletion of endogenous MLL5 can be rescued by exogenous expression of FLAG-MLL5, but not 
FLAG-MLL5ΔCD-4 or FLAG-MLL5-T912A. Endogenous MLL5 expression in HEK 293T cells were knocked down by siRNA, and FLAG-
MLL5, FLAG-MLL5ΔCD-4 or FLAG-MLL5-T912A was transfected to rescue the cell-cycle arrest. Cells were synchronized to G2 phase, and 
allowed for mitotic progression. MLL5 localization was analyzed by immunofluorescence staining using anti-FLAG antibodies (n = 50 per 
sample). FLAG-MLL5 protein dissociated from chromosomes and the cells entered mitosis after G2 release for 20 min, as shown by positive 
Histone H3Ser10 staining and chromosome condensation (1
st
 row). FLAG-MLL5ΔCD-4 and FLAG-MLL5-T912A were restricted in nuclei, and 






Figure 3-16. G2 arrest caused by the depletion of endogenous MLL5 can be 
rescued by exogenous expression of FLAG-MLL5, but not FLAG-MLL5ΔCD-4 
or FLAG-MLL5-T912A. Endogenous MLL5 expression in HEK 293T cells were 
knocked down by siRNA, and FLAG-MLL5, FLAG-MLL5ΔCD-4 or FLAG-MLL5-
T912A was transfected to rescue the cell-cycle arrest. Cells were synchronized to G2 
phase, and allowed for mitotic progression. Cumulative mitotic index was defined by 
total percentage of mitotic cells at each time point, and it was calculated for control 
cells (NC siRNA), endogenous MLL5-knockdown cells (M5 siRNA #3 or M5 siRNA 
#4), FLAG-MLL5-positive cells (M5 siRNA #4 + M5), FLAG-MLL5ΔCD-4-positive 
cells (M5 siRNA #4 + M5ΔCD-4) and FLAG-MLL5-T912A-positive cells (M5 








Figure 3-17. Western blotting showed the successful knockdown of MLL5 by different 
siRNA and the loss of phosphorylation modification of MLL5 mutants. Endogenous 
MLL5 expression in HEK 293T cells were knocked down by siRNA, and FLAG-MLL5, 
FLAG-MLL5ΔCD-4 or FLAG-MLL5-T912A was transfected to rescue the cell-cycle arrest. 
Cells were synchronized to G2 phase, and allowed for mitotic progression. MLL5 localization 
was analyzed by immunofluorescence staining using anti-FLAG antibodies. Mitotic index 
was calculated by counting the phospho-histone H3Ser10-positive cells at 20, 50 and 90 min 
post-release. A. Western blotting showed the successful knockdown of endogenous MLL5 by 
siRNA #3 and #4. B. Immunoprecipitation result showed that FLAG-MLL5ΔCD-4 and 




3.9 Summary of chapter 3 
In summary, we have investigated the cell cycle-dependent expression of MLL5. Our 
data demonstrate the dynamic phosphorylation modification on MLL5 and the 
redistribution of phosphorylated MLL5 in mitotic cells. The phosphorylation and 
localization of MLL5 is dependent on the cyclin B1/Cdk1 kinase activity, and the 
Thr912 on MLL5 is identified as Cdk1 targeting site. Ectopic over-expression of the 
MLL5-CD-4 domain obstructs mitotic progression through the competitive inhibition 
of endogenous MLL5. The functional importance of phosphorylation modification of 
MLL5 is revealed by the inability of the phosphorylation-deficient mutants (MLL5-
T912A and MLL5-ΔCD-4) to compensate for the loss of endogenous MLL5. MLL5 
has been shown to participate in the cell cycle regulatory machinery; the data 
presented here further elucidate that the phosphorylation of MLL5 on Thr912 by 




CHAPTER 4: RESULTS - Mixed Lineage Leukemia 5 Maintains 
Genomic Integrity by Regulating the Stability of the Chromosomal 
Passenger Complex 
4.1 Introduction 
Mitosis is a highly regulated process to ensure the accurate segregation of duplicated 
chromosomes to the daughter cells. Defects in mitotic fidelity cause DNA segregation 
errors and result in chromosome instability, which plays a causal role in 
tumorigenesis and relapse (Baker et al., 2009; Sotillo et al., 2010). High-throughput 
genomic profiling study reveals that most human cancers are aneuploid and 
chromosomally unstable (Beroukhim et al., 2010). The role of MLL5 in mitotic entry 
has been elucidated in Chapter 3, where MLL5 is phosphorylated by Cdk1 at the 
G2/M transition. Phospho-MLL5 dissociates from mitotic chromosomes and 
disruption of the phosphorylation modification of MLL5 on Thr912 residue impedes 
mitotic entry. Whether MLL5 plays a role in mitosis progression is still unclear. In 
this chapter, the function of MLL5 in mitotic progression and in genomic integrity 
maintenance is elucidated.  
 
4.2 Depletion of MLL5 induces chromosomal instability 
A consistent observation that about 20% of the MLL5-depleted cells became 
multinuclear was noted (Figure 4-1, n=200 for each sample, p=0.001) after siRNA 
transfection for 48 h. Considering that a large portion (~75%) of MLL5-depleted cells 
are actually arrested at G1/S phase (2N) with approximately 25% of the population 
had the chance to undergo mitosis (4N) (Cheng et al., 2008), the overall 20% of 
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mutlinucleus cells suggest that majority of MLL5-depleted cells (~80%) entering 
mitosis experienced abnormal cell division.  To determine the influence of MLL5 on 
chromosomal stability, we depleted MLL5 by two different siRNAs (MLL5-siRNA#2: 
targeting at the mRNA sequence position 1063 from the transcription start site; 
MLL5-siRNA#4: targeting to the 3’-untranslated region corresponding to mRNA 
sequence position 6807 from the transcription start site) and performed fluorescent in 
situ hybridization (FISH) to monitor the chromosome numbers in human diploid lung 
fibroblast WI-38 cells. Briefly, three plates of WI-38 cells were seeded in 60-mm 
culture dish, and transfected with negative control siRNA, MLL5 siRNA #2, and 
MLL5 siRNA #4 respectively. The siRNA transfection was repeated every other day 
to maintain MLL5 at low level for a total of 7 days, in order to verify whether 
genomic integrity was compromised when MLL5 siRNA transfected cells went 
through the first round of mitosis, and how these genetically unstable cells propagate 
in prolonged culture. After the siRNA treatment course, cells were harvested and 
centromere specific probes for chromosome 8 and 10 were used for FISH. As 
expected, majority of cells had 2 copies of both chromosomes. In MLL5-siRNA#2 
treated cells, 8.3% of population exhibited abnormal number of chromosome 8 and 
7.3% of population showed abnormal number of chromosome 10 (Figure 4-2, n>100 
cells per sample). In contrast, only 0.8% of cells from negative control sample were 
found to contain abnormal copies of chromosome 8 and 10. A similar result was 
obtained from MLL5-siRNA#4 transfected cells (Figure 4-2, n>100 cells per sample). 
In summary, there is an approximately 10-fold increase in aneuploid cells after MLL5 
was knocked down for 7 days. These data suggests that loss of MLL5 causes the mis-









Figure 4-1. Depletion of MLL5 by RNA interference results in abnormal cell 
division. The average percentage of multinucleus cells in NC- and MLL5-siRNA 
treated U2OS cells. (p=0.001, paired student t-test ). Tubulin was stained in green and 









Figure 4-2. Prolonged depletion of MLL5 in WI-38 cells resulted in genomic 
instability. MLL5 was depleted in WI-38 cells for 7 days, and the percentage of cells 
containing abnormal chromosome numbers was scored. Chromosome 8 and 
chromosome 10 were stained in red and green fluorescence conjugated probes, and 





4.3 Knockdown of MLL5 causes mitotic exit without chromosome segregation 
To understand how depletion of MLL5 leads to chromosomal instability, the mitotic 
progression of U2OS cells was monitored by flow cytometry, Western blotting and 
time-lapse video microscopy. U2OS cells were transfected with NC- or MLL5-siRNA 
for 24 h and synchronized to G2/M phase by incubating with nocodazole for 16 h. 
Mitotic cells were released in nocodazole-free medium and harvested at indicated 
time intervals. In Figure 4-3, propidium iodide staining and cell cycle analysis showed 
that while control cells completed DNA segregation by 3 h (upper panel), MLL5-
depleted cells remained at 4N DNA content even after 6 h (lower panel). Furthermore, 
the sub-G1 and polyploid populations (>4N DNA content) were gradually increased 
after release for 24, 48 and 72 h, implying that MLL5-depleted mitotic cells could 
undergo mitotic slippage to generate chromosomal unstable polyploid cells. In order 
to prove that the population containing 4N DNA content observed in MLL5-depleted 
cells have exited mitosis rather than arrested at mitosis, a double staining using anti-
phosphohistone H3Ser10 antibody and PI was carried out on NC- and MLL5-depleted 
cells (Figure 4-4). FACS analysis confirmed that MLL5-depleted cells lost 
phosphohistone H3Ser10 staining when they were released from nocodazole block, 
which suggests that MLL5-knockdown cells have exited mitosis although they failed 
in DNA segregation. 
 
To understand why the mitotic cells exited mitosis without DNA segregation, we 
further examined the mitotic progression in MLL5-depleted cells by live-cell imaging. 
To label the mitotic chromosomes, the cDNA of histone 2B was fused to mcherry 
sequence and stably expressed in U2OS cells. The mitotic progression for the control 
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and MLL5-depleted cells was recorded using fluorescence video microscopy (Figure 
4-5). Majority of control cells completed mitosis within 1 h, but MLL5-depleted cells 
exited mitosis without chromosome alignment at metaphase and no DNA segregation 
was observed. In addition, by the time of 1.5 h, the DNA in MLL5-depleted cells 
showed signs of de-condensation, and the formation of multinucleus cells was visible. 
These data indicate that MLL5-depleted cells have difficulty in aligning the 






Figure 4-3. Depletion of MLL5 induced the formation of polyploid cells. U2OS cells were transfected with NC- or MLL5-siRNA and 
synchronized to G2/M phase by nocodazole. Mitotic cells were collected and released in nocodazole-free medium and harvested at indicated time 





Figure 4-4. Mitotic cells depleted of MLL5 exited mitosis without DNA 
segregation. U2OS cells were transfected with NC- or MLL5-siRNA and 
synchronized to G2/M phase by nocodazole. Mitotic cells were collected and released 
in nocodazole-free medium and harvested at indicated time intervals. The cells were 






Figure 4-5. Mitotic cells depleted of MLL5 exited mitosis without DNA segregation. U2OS cells expressing mcherry-H2B were transfected 
with NC- or MLL5-siRNA and synchronized to G2/M phase by nocodazole. Mitotic cells were collected and released in nocodazole-free 
medium, and the mitotic progression was recorded using fluorescence video microscopy (Ten cells were live-imaged for the mitotic progression 
for both samples). Images were taken every 3 min for a total of 4 h. Scale bar, 10 µm.  
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4.4 The activity of APC/C appears not affected by MLL5-depletion 
The anaphase-promoting complex/cyclosome (APC/C) is a key player in mitotic 
progression, and is part of the machinery that promotes the metaphase-anaphase 
transition by mediating the ubiquitin-dependent destruction of anaphase inhibitors and 
mitotic cyclins (Morgan, 1999; Pines, 2006). Since APC/C is required for the 
segregation of sister chromatids and cytokinesis, we performed a time-course study to 
examine whether the activity of APC/C was affected in MLL5-depleted mitotic cells. 
As shown in Figure 4-6, upon release from nocodazole, the rate of cyclin B1 
degradation was only slightly slower in MLL5-depleted cells, and by 120 min cyclin 
B1 was completely degraded in MLL5-siRNA treated samples. This finding implies 
that the APC/C was still functional after MLL5 was knocked down.  
 
 
Figure 4-6. The APC/C function was not affected by MLL5-depletion. U2OS cells 
were transfected with NC- or MLL5-siRNA and synchronized to G2/M phase by 
nocodazole. Mitotic cells were collected and released in nocodazole-free medium and 
harvested at indicated time intervals. Total cell extract was prepared and the 
expression of MLL5, cyclin B1 were studied by Western blotting.  Actin served as 





4.5 The activation of mitotic checkpoint is not affected by the knockdown of 
MLL5 
Although the APC/C activity seems not affected by the depletion of MLL5, the 
robustness of the mitotic checkpoint, which inhibits the activity of APC/C until all 
chromosomes are properly aligned at metaphase, should not be neglected. To assess 
the mitotic checkpoint function after MLL5-depletion, U2OS cells were transfected 
with NC- or MLL5-siRNA and synchronized to G2/M phase by nocodazole which 
depolymerizes microtubules. Mitotic cells were stained with the spindle assembly 
checkpoint protein BubR1 and MAD2 and the localization of the checkpoint protein 
was examined by fluorescence microscopy (Figure 4-7). Results showed that MAD2 
co-localized well with the kinetochore marker CREST, suggesting that the unattached 
kinetochores resulting from nocodazole treatment could be detected by MAD2 in both 
NC- and MLL5-siRNA treated cells; however BubR1 in MLL5-depleted cells was 
delocalized from kinetochores, indicating that the loss-of-inter-kinetochore-tension 
induced by nocodazole treatment could not activate BubR1 after depletion of MLL5. 
This data implies that the mitotic checkpoint can still be activated after nocodazole 
treatment in MLL5-siRNA transfected cells; nonetheless, the delocalization of BubR1 
after MLL5-depletion may fail to activate the downstream effectors, and in 








Figure 4-7. BubR1 in MLL5-depleted cells was delocalized from kinetochores. 
U2OS cells were transfected with NC- or MLL5-siRNA and synchronized to G2/M 
phase by nocodazole. Mitotic cells were stained with BubR1 or MAD2 (n=50 per 





To further characterize the checkpoint response after MLL5 repression, MLL5-
depleted cells were tested for how long they can sustain a mitotic delay in the 
presence of nocodazole and taxol. Nocodazole depolymerizes microtubules, thus 
results in both unattached kinetochores and loss-of-inter-kinetochore-tention; whereas 
taxol stabilizes microtubules, which reduces inter-kinetochore tension by preventing 
the kinetochore-microtubule dynamics (Musacchio and Salmon, 2007). Briefly, NC- 
and MLL5-siRNA treated cells were incubated with nocodazole or taxol for 16 hours. 
Mitotic cells were collected by shaking-off from culture plate, and re-plated into new 
culture dishes. At each indicated time point, samples were fixed and double stained 
with PI and phosphohistone H3Ser10 antibody to quantify the percentage of cells 
successfully sustained a mitotic arrest in response to checkpoint activation (Figure 4-
8). In nocodazole-induced mitotic arrest condition, MLL5-depleted cells could 
maintain checkpoint activation until 24 h, after that, they exit mitosis slightly faster 
than the NC-siRNA transfected cells. In taxol treatment condition, both NC- and 
MLL5-siRNA treated cells could hardly sustain mitotic arrest for 24 h, indicating that 
taxol treated cells went through mitotic slippage easier than nocodazole treated cells. 
In addition, MLL5-depleted cells seemed to exit mitosis faster than NC-siRNA treated 
cells.  These findings suggest that the activation of the spindle assembly checkpoint is 
not affected in MLL5-depleted cells after treating with microtubule-damaging drugs; 
however, sustained checkpoint activation in MLL5-depleted cells may be affected, as 
they could not maintain prolonged mitotic checkpoint activation as compared to the 










Figure 4-8.  MLL5-depleted cells have a weaker mitotic checkpoint response. 
U2OS cells were transfected with NC- or MLL5-siRNA for 24 h, and subsequently 
incubated with nocodazole (A) or taxol (B) for 16 h. Mitotic cells were collected by 
shaking-off from culture plate, and replated into 6-well plate. The time indicated the 
duration of nocodazole or taxol treatment. At each time point, samples were fixed, 
double stained with PI (x-axis) and phosphohistone H3Ser10 antibody (y-axis), and 
analyzed by flow cytometry. The percentage below each graph indicated the 
percentage of mitosis-arrested cells with positive phosphohistone H3Ser10 staining.   
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4.6 Depletion of MLL5 causes defective chromosome alignment at metaphase 
To further understand the consequence of MLL5 depletion on chromosome bi-
orientation, mitotic cells expressing mcherry-H2B were released into medium 
containing proteasome inhibitor (20 µM MG132) which blocked the activation of 
APC/C and prevented the anaphase onset. The chromosome alignment process for the 
control and MLL5-depleted cells was monitored by live-cell imaging. Strikingly, 
MLL5-depleted cells failed to align the chromosomes at metaplate even after 2 h of 
release, while control cells almost reached complete alignment after only 12 min of 
release (Figure 4-9).  To further analyze the chromosome bi-orientation process, 
indirect immunofluorescence on fixed cells were performed. Briefly, U2OS cells were 
transfected with NC- or MLL5-siRNA and synchronized to G2/M phase by 
nocodazole. Mitotic cells were collected and released in fresh medium containing 
MG132 (20 µM) for 90 min. Metaphase arrested cells were fixed in methanol and 
stained with α-tubulin and CREST antibodies, and chromosomes were counterstained 
with DAPI. Metaphase cells were categorized into three groups: bipolar normal 
alignment (bipolar spindle with chromosomes aligned on the equatorial plate), bipolar 
misalignment (bipolar spindle with chromosomes lined up randomly between the 
spindle poles), and multipolar misalignment (more than two mitotic spindles with 
chromosomes lined up randomly between the spindle poles). Cell counting results 
revealed that 93.4% of control cells achieved full chromosome alignment by the time 
of fixation. Whereas only 16.1% of MLL5-depleted cells exhibited aligned 
chromosomes with bipolar spindles; 83.9% of them displayed mis-aligned 
chromosomes with either bipolar spindles (44.5%) or multi-polar spindles (39.4%) 
(Figure 4-10). Taken together, these data support that the absence of MLL5 causes 






Figure 4-9. MLL5-depleted cells failed to align chromosomes on metaplate. U2OS cells expressing mcherry-H2B were transfected with NC- 
or MLL5-siRNA and synchronized to G2/M phase by nocodazole. Mitotic cells were collected and released in fresh medium containing MG132 
(20µM), and the chromosome alignment process was recorded using fluorescence video microscopy. Images were taken every 3 min for a total 







Figure 4-10. A dramatic increase in cells carrying misaligned chromosomes was 
observed after MLL5 was depleted. U2OS cells were transfected with NC- or 
MLL5-siRNA and synchronized to G2/M phase by nocodazole. Mitotic cells were 
collected and released in fresh medium containing MG132 (20 µM) for 90 min. 
Metaphase arrested cells were fixed and stained with α-tubulin and CREST antibodies, 
DNA was counterstained with DAPI. Mitotic cells were categorized into three groups: 
bipolar normal alignment, bipolar misalignment, and multipolar misalignment. 
Experiments were repeated three times and the average percentage was presented. 
Scale bar, 5 µm. 
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4.7 The kinetochore capture and MT attachment process are not affected by the 
knockdown of MLL5 
There are many factors contributing to the chromosome misalignment, including 
defective kinetochore-MT (microtubule) attachment or inability to correct alignment 
errors during chromosome bi-orientation (DeLuca et al., 2006; Jelluma et al., 2008). 
To discriminate between these possibilities, the kinetochore-MT attachment in MLL5-
depleted cells was examined. When the MT plus-ends directly embed into the 
kinetochore, these MTs form a bundle referred to as a kinetochore fiber. The 
kinetochore fibers are resistant to cold-induced depolymerization; whereas the labile 
MTs are sensitive to low temperature and depolymerize upon the cold treatment. To 
determine whether stable kinetochore-MT attachments are present in MLL5-depleted 
metaphase arrested cells, cells were subjected to cooling in an ice bath in order to 
depolymerize labile MTs. After cold treatment, cells were immunostained with α-
tubulin antibody and the amount of kinetochore fiber was compared between NC- and 
MLL5-siRNA transfected cells. As shown in Figure 4-11, no obvious difference in the 
density of cold-stable kinetochore fibers was detected between the control and MLL5-
depleted cells, suggesting that the kinetochore capture and MT attachment process 
might not be affected by the knockdown of MLL5. 
  
To further prove the hypothesis, an indirect experiment to assess the kinetochore-MT 
attachment by immunofluorescence staining for MAD2 in nocodazole and monastrol 
treated cells was performed. MAD2 dissociates from kinetochores as soon as the 
microtubules and kinetochores are attached, therefore by comparing the MAD2 status 
in nocodazole and monastrol treated cells, the changes for the kinetochore level of 
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MAD2 induced by depletion of MLL5 would be revealed. Nocodazole depolymerizes 
microtubules and results in unattached kinetochores. In this case, MAD2 should be 
detected in both NC- and MLL5-siRNA treated cells. While monastrol induces 
monopolar spindle with chromosomes syntelically attached to microtubules, in which 
only unattached kinetochores can generate MAD2 signal. By comparing the MAD2 
signal in NC- and MLL5-depleted cells after monastrol treatment, the effect of 
MLL5-knockdown on kinetochore-MT attachment can be investigated.  In brief, 
U2OS cells were transfected with NC- or MLL5-siRNA for 24 h, and subsequently 
treated with nocodazole or monastrol for 14 h. Cells were fixed with methanol and 
stained with anti-MAD2 antibody.  As shown in Figure 4-12, MAD2 staining was 
detected in both NC- and MLL5-siRNA transfected cells in response to nocodazole or 
monastrol treatment, and there was no perceptible difference in signal intensity. In 
agreement with the cold-induced depolymerization assay result, this data suggests that 
knockdown of MLL5 does not affect the efficiency of microtube-kinetochore 










Figure 4-11. The kinetochore-MT capture and attachment process were not 
affected by the knockdown of MLL5 in a cold-induced MT depolymerization 
assay. U2OS cells were transfected with NC- or MLL5-siRNA and synchronized to 
G2/M phase by nocodazole. Mitotic cells were released and incubated with fresh 
medium containing 20 µM MG132 for 1.5 h. Before methanol fixation, cells were 
incubated in ice-cold medium for 10 min to depolymerise microtubules which are not 
bound to kinetochores. Kinetochore fibers were stained with α-tubulin antibody and 
kinetochores were labeled with CREST. Images were taken using confocal 




Figure 4-12. The basal kinetochore level of MAD2 appears not affected by the depletion of MLL5. U2OS cells were transfected with NC- 
or MLL5-siRNA for 24 h, and then treated with nocodazole (100 ng/ml) or monastrol (10 µM) for 14 h. Cells were stained with MAD2 (green), 
CREST (red) and α-tubulin (green) antibodies (n=50 cells for each sample). DNA was counterstained with DAPI. Scale bar, 5 µm.  
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4.8 Depletion of MLL5 affects the function of the kinetochore-MT attachment 
error correction machinery 
Chromosome segregation mainly depends on the forces that are generated by 
microtubules that attach to kinetochores. For high fidelity chromosome segregation, 
each sister kinetochore must attach to microtubules that extend from opposite spindle 
poles, which is known as amphitelic attachment (Figure 1-3). When amphitelic 
attachment is achieved, the tension that is established across the centromere region, 
causes stretching of the centromeric chromatin and leads to an increase in the distance 
between the two sister kinetochores. In order to gauge the inter-kinetochore tension 
generation in MLL5-depleted cells, the average inter-kinetochore distance between 
two sister kinetochores was measured by confocal microscopy. Briefly, metaphase-
arrested cells were fixed in methanol and stained with α-tubulin and CREST 
antibodies. For inter-kinetochore distance measurement, a stack of images with 0.46 
µm step size in the z-direction was obtained for each cell. Sister kinetochores were 
identified by their presence in the same plane of focus. A single line was drawn 
between the brightest pixels of each kinetochore pair and the length of the line was 
recorded. The average inter-kinetochore distance of sister kinetochores for the control 
and MLL5-depleted cells was 0.93 µm and 0.61 µm respectively (NC siRNA: n=70, 
MLL5 siRNA: n=84 pairs of kinetochores) (Figure 4-13). The decrease (34.4%) in the 
inter-kinetochore distance after knockdown of MLL5 reflected the impaired 
generation of the inter-kinetochore tension, inferring that the kinetochore-MT 




From these data, we may deduce that the function of the kinetochore-MT attachment 
error correction machinery may be affected by MLL5-depletion. To test this 
hypothesis, an Eg-5 inhibitor (monastrol) washout experiment was conducted (Figure 
4-14) (Kapoor et al., 2000). Treatment of cells with monastrol resulted in the 
accumulation of mitotic cells with monopolar spindles and the formation of syntelic 
attachment of sister kinetochore pairs. Upon removal of the drug, monopolar spindles 
were converted to bipolar spindles, and syntelic attachment was replaced with 
amphitelic attachment. NC- or MLL5-depleted U2OS cells were released from 
monastrol and allowed to achieve chromosome alignment in the presence of MG132, 
which was added to prevent the anaphase onset. Samples were fixed in methanol 
every 20 min and stained with α-tubulin and CREST antibodies to examine the 
efficiency of correcting the chromosome mis-alignment. As shown in Figure 4-13 
right panel, by 60 min of release, 89.3% of cells achieved chromosome bi-orientation 
in control cells. A small portion 7.1% and 2.7% of cells exhibited bipolar and 
multipolar spindles containing misaligned chromosomes in the control population. In 
contrast, only 6.4% of MLL5-depleted cells achieved chromosome bi-orientation after 
60 min of release, and 90.9% of MLL5-depleted cells contained mis-aligned 
chromosomes with either bipolar (53.6%) or multipolar spindles (37.3%). This 
observation suggests that the function of the kinetochore-MT attachment error 









Figure 4-13. The inter-kinetochore distance after MLL5-depletion was reduced. 
U2OS cells were transfected with NC- or MLL5-siRNA and synchronized to G2/M 
phase by nocodazole. Mitotic cells were released and incubated with fresh medium 
containing 20 µM MG132 for 1.5 h. Cells were fixed and stained with α-tubulin 
(green), CREST (red) and DAPI (blue). For inter-kinetochore distance measurement, 
a stack of images with 0.46 µm step size in the z-direction was obtained for each cell. 
Images were analyzed using Image J software, and sister kinetochores were identified 
by their presence in the same plane of focus. A single line was drawn between the 
brightest pixels of each kinetochore pair and the length of the line was recorded. The 
average interkinetochore distance of sister kinetochores for control cells (n=70) and 









Figure 4-14. The conversion of syntelic attachment to amphitelic attachment in 
cells released from monastrol was compromised by MLL5-depletion. NC- or 
MLL5-depleted U2OS cells were released from monastrol and allowed to achieve 
chromosome alignment for a total of 60 min in the presence of MG132. Samples were 
fixed every 20 min to examine the efficiency of correcting the chromosome mis-
alignment. Cells were stained with α-tubulin (green), CREST (red) and DAPI (blue) 
and categorized into four groups: monopolar, bipolar misalignment, multipolar 
misalignment and bipolar normal alignment; and the percentage of each group at each 




4.9 MLL5-depletion causes the destabilization of the chromosomal passenger 
complex 
During the chromosome bi-orientation process, mal-orientated kinetochore-spindle 
connections are destabilized and corrected until all kinetochores are captured properly 
on the mitotic spindle before anaphase onset. Correction of aberrant kinetochore-MT 
attachment is highly dependent on CPC, which selectively destabilizes the 
kinetochore-MT interaction of erroneous attached chromosomes, allowing the 
reattachment to occur (Carmena et al., 2009; Ruchaud et al., 2007; Vader et al., 2006). 
To investigate whether the knockdown of MLL5 has any effects on the CPC function, 
the localization of CPC at metaphase were studied in MLL5-depleted cells. Instead of 
displaying the typical inner centromere localization at metaphase in control cells 
(Figure 4-15, upper panel), strikingly none of the four subunits of CPC were 
detectable in the MLL5-depleted cells (Figure 4-15, lower panel). The delocalization 
of the CPC may be due to mis-localization or reduction in the expression of each 
subunit. Since the expression of the CPC components is cell cycle-dependent (Honda 
et al., 2003; Terada et al., 1998; Zhao et al., 2000), we proceeded to compare the 
expression of CPC in S, G2 and M phase in control and MLL5-knockdown cells by 
Western blotting. Consistent with previous reports, the expression of the CPC 
components was cell cycle-dependent with the highest level at M phase (Figure 4-16A, 
NC-siRNA group); however, a dramatic loss of expression of all CPC components 
was seen in MLL5-siRNA treated cells throughout the S, G2 and M phases (Figure 4-
16A). The successful synchronization of the NC- and MLL5-depleted cells into each 






Figure 4-15. The CPC was delocalized in MLL5-depleted cells. U2OS cells were 
transfected with NC- or MLL5-siRNA, and synchronized to metaphase. The 
localization of CPC was examined by immunofluorescence staining (n=100 cells in 









Figure 4-16. The expression of CPC was down regulated in MLL5-depleted cells. 
NC and MLL5-siRNA transfected cells were synchronized to S, G2 or M phase. A. 
The expression of Aurora-B, Survivin, Borealin and INCENP was analyzed by 
Western blotting. α-tubulin served as loading control. B. FACS analysis to 
demonstrate the successful synchronization of cells after siRNA transfection and drug 




Next, we asked whether such down regulation of CPC was at a transcriptional or 
translational level. Quantitative real-time reverse-transcription PCR (qRT-PCR) 
results showed that the mRNA level of all CPC components after MLL5-knockdown 
was not significantly affected (within 2-fold changes in mRNA level) (Figure 4-17). 
Conversely, treatment of MG132 in MLL5-depleted cells substantially restored the 
expression of all CPC components regardless of cell cycle stages as shown in Figure 
4-18, suggesting that the CPC is likely degraded through the proteasome pathway in 
MLL5-knockdown cells. We went on to ask whether blocking of the CPC degradation 
by MG132 treatment could also restore the localization of CPC in MLL5-knockdown 
cells. Briefly, NC- or MLL5-depleted mitotic cells were treated with MG132 for 4 h, 
and the localization of the CPC was examined by immunofluorescence staining. 
Interestingly, none of the CPC subunits could re-localize to the inner centromere 
region even though the expression of the CPC could be rescued by MG132 in MLL5-
depleted mitotic cells (Figure 4-19). The failure in restoring the correct localization of 
CPC by MG132 may be due to a few possibilities. First, MLL5 may be needed for the 
assembly of the complex, so that even though the subunits are there but they do not 
form complex. Secondly the level of protein restored may not be high enough for the 
formation of the complex. Thirdly the treatment of MG132 may interfere with some 
other cellular targets which in turn inhibit the assembly of the complex or inhibit the 
recruitment of the complex to the inner centromere. Nonetheless, the data from 
MG132 treatment suggest that the presence of MLL5 in cells protects CPC from the 
proteasome-mediated degradation, and facilitates the accumulation and assembly of 





Figure 4-17. Quantitative RT-PCR study showed that the mRNA level of all CPC 
components after MLL5-knockdown was not significantly affected. U2OS cells 
were transfected with NC- or MLL5-siRNA and synchronized to G2/M phase by 
nocodazole. Mitotic cells were collected and total RNA was extracted. The mRNA 
expression level for each CPC component was compared between NC- and MLL5-
siRNA treated samples.  
 
Figure 4-18. Blocking of the proteasome pathway by MG132 restored the 
expression of CPC substantially in MLL5-depleted cells. NC and MLL5-siRNA 
transfected U2OS cells were synchronized to S, G2 or M phase. Cells were then 
subjected to MG132 treatment for 4 h before harvested for Western blotting. The 
expression of Aurora-B, Survivin, Borealin and INCENP was analyzed by Western 





Figure 4-19. Blocking of the proteasome pathway by MG132 failed to restore the localization of CPC in MLL5-depleted cells. NC and 
MLL5-siRNA transfected cells were synchronized to M phase by nocodazole. Cells were released from nocodazole and then subjected to 
MG132 treatment for 4 h. The expression and localization of Aurora-B, Survivin, Borealin and INCENP were examined by immunofluorescence 
staining (n=100 cells in each sample). CREST served as kinetochore marker. Scale bar, 5µm. 
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4.10 MLL5 maintains the stability of CPC through interacting with Borealin 
 Studies have shown that the localization and/or stability of the CPC subunits are 
inter-dependent (Honda et al., 2003; Klein et al., 2006); however, there is no 
systematic analysis on the effects of protein expression in mitotic cells by knocking 
down each of the subunits. Here we depleted Aurora B, Survivin, INCENP, Borealin 
and MLL5 by siRNA individually and compared the expression of the rest protein by 
Western blotting.  As shown in Figure 4-20, Aurora B and INCENP were more 
susceptible to degradation upon knocking down of other subunits. The stability of 
Survivin was also dependent on the presence of other members. However the 
expression of Borealin appeared not greatly affected by the knockdown of Aurora B, 
Survivin or INCENP. Furthermore, Borealin-siRNA treatment resulted in the 
degradation of all other CPC components, and MLL5-depletion mimics the phenotype 
produced by Borealin siRNA. This result is inconsistent with previous finding that 
Borealin siRNA-treatment does not affect the expression of Aurora B (Gassmann et 
al., 2004), which could be due to cell type specificity or Western blotting sensitivity. 
Nonetheless, our data suggest that the down-regulation of CPC after MLL5-depletion 
is possibly due to the degradation of Borealin, which in turn leads to the 
destabilization of Aurora B, Survivin and INCENP. Indeed, studies have shown that 
Borealin forms higher order oligomers in its isolated form, and it directly interacts 
with Survivin to form a binary subcomplex that is competent to interact with INCENP 
(Bourhis et al., 2009; Zhou et al., 2009). Therefore, it is likely that Borealin may serve 
as a basic structural unit for the assembly of the CPC. In MLL5-depleted cells, the 
stability of Borealin may be affected, leading to the degradation of other CPC 
components. To test this possibility, the stability of Borealin in the control and 
MLL5-depleted cells was compared. Since the level of Borealin was undetectable 
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after knockdown of MLL5, cells were subjected to a pretreatment of MG132 for 4 h 
to restore the level of Borealin, and subsequently incubated in cycloheximide-
containing medium (200 µg/ml) to block the de novo protein synthesis. As presented 
in Figure 4-21, Borealin in MLL5-depleted cells showed a decreased half-life 





Figure 4-20. Protein stability inter-dependency among CPC subunits. U2OS cells 
were transfected with NC- or MLL5-siRNA and synchronized to G2/M phase by 
nocodazole. Mitotic cells were collected and total RNA was extracted. The expression 
of Aurora-B, Survivin, Borealin and INCENP was analyzed by Western blotting. 









Figure 4-21. Depletion of MLL5 decreased the half-life of Borealin. U2OS cells 
were transfected with NC or MLL5-siRNA and synchronized to M phase. Cells were 
treated with MG132 for 4 h to restore the level of Borealin, and subsequently 
incubated in cycloheximide-containing medium to block the de novo protein synthesis. 
At each indicated time point, total cell extract was prepared and the expression of 
Borealin was analyzed by Western blotting. Tubulin served as loading control.CHX, 





The above data suggests that MLL5 plays a role in regulating the stability of Borealin, 
but the underlying mechanism is unknown. Since MLL5 is localized to the chromatin 
compartment in interphase (Liu et al., 2010), and Borealin is also localized to the 
nucleus in interphase cells (Rodriguez et al., 2006), we sought the possibility of 
interactions between MLL5 and Borealin.  As demonstrated in Figure 4-22A, 
endogenous MLL5 was immunoprecipitated by anti-MLL5 antibody from cell lysates 
that were harvested from different cell cycle stages. Borealin was found to co-
immunoprecipitate with MLL5 throughout the G1, S and G2 phases; however, Aurora-
B, Survivin and INCENP were undetectable. To further confirm the interaction 
between MLL5 and Borealin, immunoprecipitation using HA-Borealin was carried 
out, and MLL5 was detected in the eluate (Figure 4-22B). The double bands seen on 
Borealin blot in the IP eluates might be due to post-translational modification (Kaur et 
al., 2007; Klein et al., 2009). 
 
To gain more insights into the interaction between MLL5 and Borealin, a pull-down 
assay was performed using recombinant GST-Borealin and in vitro translated MLL5. 
Instead of using full length MLL5, the PHDSET (PS), central domain (CD) and c-
terminal fragments (CT) of MLL5 (Figure 2-1) were used in the in vitro translation 
studies due to the higher translation efficiency and protein stability. The central 
domain of MLL5 was found to efficiently interact with Borealin, suggesting that the 
association between MLL5 and Borealin is direct and mediated by the central domain 
(Figure 4-23). Similarly, we constructed Borealin deletion mutants and attempted to 
delineate which region of Borealin interacts with the central domain of MLL5 by co-
immunoprecipitation. Our results showed that both the N-terminal and the C-terminal 
of Borealin could pull-down the central domain of MLL5 as efficiently as their full 
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length counter-part (Fig. 4-24). Since both the N- and C-terminal of Borealin interact 
with wild type Borealin (Gassmann et al., 2004), the equal co-immunoprecipitation 
efficiency observed here could possibly attribute to the oligomerization of the 
Borealin mutants with endogenous Borealin. Although the association between MLL5 
and other CPC subunits was not established, the direct interaction between MLL5 and 
Borealin suggests that MLL5 may facilitate the assembly of the CPC in the nucleus 








Figure 4-22. The interaction between MLL5 and Borealin was revealed by co-
immunoprecipitation studies. A. U2OS cells were synchronized to G1/S phase by 
double thymidine block, S phase cells were collected 4 h after G1 phase release. G2 
synchronization was done by incubating with RO-3306 for 16 h. MLL5 was 
immonoprecipitated from cell lysate and the eluted protein was analyzed by Western 
blotting for the presence of Aurora B, Survivin, INCENP and Borealin. B. HA-
Borealin and FLAG-MLL5 were co-expressed in HEK 293T cells for 48 h, and 




Figure 4-23. Direct interaction between the central domain of MLL5 and 
Borealin was established by in vitro binding assay. The PHDSET domain (PS), 
central domain (CD) and C-terminal domain (CT) of MLL5 were synthesized by in 
vitro transcription and translation system. GST and GST-Borealin were induced and 
purified from bacterial system. The GST and GST-Borealin beads were incubated 
with fragments of MLL5, and the interaction between MLL5 and Borealin was 
analyzed by Western blotting.   
 
Figure 4-24. Co-immunoprecipitation studies showed that both the N-terminal 
and C-terminal of Borealin interacted with the central domain of MLL5 in HEK 
293T cells. The central domain of MLL5 (M5-CD) and the full length Borealin 
(Borealin FL), N-terminal domain of Borealin (Borealin-N, aa 1-120) and C-terminal 
domain of Borealin (Borealin-C, aa 121-280) were co-expressed in HEK 293T cells 





4.11 Over-expression of FLAG-MLL5 rescues the expression of CPC in 
endogenous MLL5-knockdown cells 
To further substantiate the significance of the association between MLL5 and 
Borealin on the stability of the CPC, rescue experiments were conducted in MLL5-
depleted cells by ectopic over-expression of wild type MLL5 (FLAG-MLL5), MLL5 
with central domain-deletion mutant (FLAG-MLL5∆CD) and Borealin (HA-Borealin). 
Since MLL5∆CD cannot enter mitosis due to the loss of the phosphorylation domain 
(Figure 3-15), we first compared the expression of the CPC at G2 phase. Briefly, 
endogenous MLL5 was knocked down by siRNA which targets at the 3’ un-translated 
region, so that it would not affect the over-expression of FLAG-MLL5 and FLAG-
MLL5∆CD. After 16 h of siRNA transfection, FLAG-MLL5, FLAG-MLL5∆CD and 
HA-Borealin were introduced into the cells for 8 h, followed by treating with RO-
3306 for another 16 h. The expression of CPC was examined by indirect 
immunofluorescence staining and results were shown in Figure 4-25. The CPC 
displayed nuclear localization in control cells (NC-siRNA), but the expression was 
lost after MLL5 was knocked down (MLL5-siRNA). After FLAG-MLL5 over-
expression, the expression of all CPC components was restored. In contrast, the over-
expression of MLL5 mutant (FLAG-MLL5∆CD), which does not contain the domain 
required for the interaction with Borealin, failed to rescue the expression of CPC. This 
data confirmed our hypothesis that the interaction between MLL5 and Borealin 
facilitates the accumulation of CPC components in the nucleus at G2 phase. In 
addition, the successful restoration of the CPC in MLL5-depleted cells by over-
expression of HA-Borealin suggests that the destabilization of CPC subunits was 




Figure 4-25. The expression of the CPC at G2 phase after MLL5-knockdown was rescued by FLAG-MLL5 and Borealin, but not 
MLL5∆CD. MLL5 was knocked down by siRNA which targets at the 3’ un-translated region in HEK 293T cells. After 16 h of siRNA 
transfection, FLAG-MLL5, FLAG-MLL5∆CD and HA-Borealin were introduced into the cells for 8 h, followed by treating with RO-3306 for 
another 16 h. The expression of CPC was examined by indirect immunofluorescence staining (100 cells were examined for each group). Scale 
bar, 10 µm. 
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We have shown that the down-regulation of CPC subunits in MLL5-depleted cells are 
rescued by ectopic over-expression of MLL5 or Borealin, but whether the function of 
the CPC can be restored is unclear. Therefore, another rescue experiment which 
intends to check the CPC activity in chromosome alignment in mitotic cells was 
carried out. In short, after 16 h of MLL5-siRNA transfection, FLAG-MLL5 and HA-
Borealin were introduced into the cells for 8 h, followed by treating with nocodazole 
for another 16 h. Mitotic cells were collected and released in fresh medium containing 
20 µM MG132 for 1 h to allow for chromosome alignment at metaphase. The 
chromosome alignment and the localization of CPC were examined by indirect 
immunofluorescence staining and results were shown in Figure 4-26. The CPC in 
control metaphase cells displayed typical inner centromere localization in mitotic cells 
(first panel). After MLL5-depletion, mitotic chromosomes failed to align at the 
metaplate and the expression of CPC was no longer detectable (second panel). 
Importantly, after over-expression of FLAG-MLL5 or HA-Borealin, the localization 
of CPC and the chromosome bi-orientation were fully restored in these cells (third 
and fourth panels). The efficiency of the rescue was also assessed and results showed 
that the percentage of mitotic cells displaying normal chromosome alignment 
increased from 19.8% to 63.9% after FLAG-MLL5 expression in the MLL5-depleted 
cells. Similarly, over-expression of HA-Borealin also increased the percentage of cells 
displaying chromosome bi-orientation to almost 50% (Figure 4-26B). The successful 
functional restoration of the CPC by exogenous over-expression of FLAG-MLL5 and 
HA-Borealin indicates a direct causal relation between MLL5 depletion and the 
















Figure 4-26. The localization of CPC and chromosome alignment can be rescued 
by FLAG-MLL5 and HA-Borealin over-expression in MLL5-siRNA treated cells. 
MLL5 was knocked down in HEK 293T cells by siRNA duplex targeting to the 3’ 
untranslated region for 16 h. Subsequently, FLAG-MLL5 and HA-Borealin were 
transfected into these cells for 8 h, followed by additional 16 h of incubation with 
nocodazole. Mitotic cells were harvested and released into MG132 medium for 1 h for 
metaphase synchronization. A. The expression of the CPC in control cells (NC 
siRNA), MLL5-depleted cells (MLL5 siRNA), FLAG-MLL5 over-expression cells 
(MLL5 siRNA + FLAG-MLL5), and HA-Borealin over-expression cells (MLL5 
siRNA + HA-Borealin) were examined by immunofluorescence staining. CPC was 
stained in green, FLAG-MLL5 and HA-Borealin in red. Scale bar, 5µm. B.The rescue 
experiments were repeated 3 times and the average percentage was presented (n=100 
cells per sample). 
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4.12 Summary of chapter 4 
In this study, we have investigated the role of MLL5 in mitosis regulation. 
Characterization of the mitotic progression of MLL5-depleted cells by live-cell 
imaging and immunofluorescence staining reveals that knockdown of MLL5 causes 
defective chromosome alignment at metaphase, which is attributed to the down-
regulation of the chromosomal passenger complex. Interaction studies and rescue 
experiments further prove that MLL5 facilitates the accumulation of the CPC in 
interphase cells, through functionally interacting with Borealin. When MLL5 is absent, 
Borealin may lose its interacting partner, thus undergoes proteasome-mediated 
degradation, which further leads to the destabilization of the whole complex. Such a 
massive destruction of the CPC impairs the correction of the kinetochore-MT 





CHAPTER 5- DISCUSSION 
5.1 Summary of results 
Emerging evidence suggest that MLL5 has important functions in adult hematopoiesis, 
chromatin regulation, and cell cycle control. This study aims to delineate the 
molecular mechanism of MLL5 in mitosis regulation.  Our data demonstrate that 
MLL5 is tightly regulated through phosphorylation on its central domain at the G2/M 
phase of cell cycle. Upon entry into mitosis, the phosphorylated MLL5 delocalizes 
from condensed chromosomes; while after mitotic exit, MLL5 becomes 
dephosphorylated and re-associates with the relaxed chromatin. The phosphorylation 
site on MLL5 is further mapped to threonine 912, and the phosphorylation and sub-
cellular localization of MLL5 is dependent on Cdk1 activity. Over-expression of the 
Cdk1-targeting domain obstructs mitotic entry by competitive inhibition of the 
phosphorylation of endogenous MLL5. In addition, G2 phase arrest caused by the 
depletion of endogenous MLL5 can be compensated by exogenously over-expressed 
full-length MLL5, but not the phospho-domain deletion or T912A mutant. These data 
provide evidence that MLL5 is a novel substrate of Cdk1 and phosphorylation of 
MLL5 on Thr912 is required for mitotic entry. 
 
Both the knockdown of MLL5 and disruption on the phosphorylation of MLL5 result 
in cell cycle arrest at G2 phase, suggesting that MLL5 and its phosphorylation may 
play a role in mitotic progression. By using the siRNA-mediated knockdown of 
MLL5, the role of MLL5 in mitotic cells is further investigated.  Our results show that 
depletion of MLL5 by RNA interference results in chromosomal instability and leads 
to genetically unstable polyploid cells. Live-cell imaging further suggests that MLL5-
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depleted mitotic cells fail to align the chromosomes at metaphase and consequently 
exit mitosis without DNA segregation. The mechanism underlying the chromosome 
bi-orientation defects in MLL5-depleted cells is further studied. Our data show that 
MLL5-depletion neither affects the activity of APC nor blocks the spindle checkpoint 
signaling. Instead, MLL5-depletion destabilizes the chromosomal passenger complex 
which is responsible for the correction of chromosome alignment errors during 
chromosome bi-orientation. Biochemical studies further reveal that MLL5 maintains 
the stability of CPC by direct interacting with Borealin through the central domain. 
Knockdown of MLL5 renders Borealin protein unstable, which in turn prevents the 
accumulation of CPC. Moreover, the CPC expression and chromosomal bi-orientation 
in MLL5-depleted cells can be restored by ectopic overexpression of MLL5 and 
Borealin but not MLL5 mutant, which does not contain the domain required for 
Borealin binding. Collectively, these results suggest that MLL5 facilitates the 
assembly of the CPC, allowing for the spatial and temporal expression of the CPC, 
and hence contributes to mitotic fidelity and genomic integrity. 
 
Combining all the data, we would like to propose a molecular model on how MLL5 is 
regulated during G2/M transition, and how MLL5 contributes to mitotic fidelity 
through modulating the stability of the CPC. As shown in Figure 5-1, in interphase 
cells, MLL5 localizes to the chromatin compartment and such localization of MLL5 
facilitates the assembly of the CPC through direct interacting with Borealin. When 
cells enter mitosis, upon the activation of the cyclin B1/Cdk1, MLL5 is 
phosphorylated on Thr912 and dissociated from the chromatin. Meanwhile the active 
Cdk1 phosphorylates Borealin and promotes its interaction with the centromeric 
adaptor Shugoshin (Tsukahara et al., 2010; Yamagishi et al., 2010). At the same time, 
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phosphorylation of Thr3 on histone H3 by Haspin recruits Survivin onto the 
centromeric region of the chromatin (Kelly et al., 2010; Wang et al., 2010). It is likely 
that MLL5 not only provides an assembly point for the CPC in interphase, but also 
brings the CPC and its chromatin targets into close proximity, thus allowing the 
recruitment of the CPC to the centromere through binding to Shugoshin and phospho-
histone H3 Thr3 at mitosis. In contrast, in MLL5-depleted cells, Borealin loses its 
interacting partner, and undergoes proteasome-mediated degradation, which in turn 
results in the failure of CPC accumulation. Such cells should be arrested at either G1 
or G2 phase, and eventually be eliminated by apoptosis. However, if these cells get the 
chance to enter mitosis, they will have problems to align chromosomes at metaphase 
due to loss of function of the CPC, and exit mitosis without cytokinesis, which will 
further lead to aneuploidy and threaten the genomic stability. In conclusion, this study 
reveals the molecular mechanism underlying the mitosis regulatory role of MLL5, and 





Figure 5-1. Proposed model on the role of MLL5 in mitosis regulation. In 
interphase cell, MLL5 provides an anchoring point for the assembly of the CPC and 
maintains the stability of CPC by directly interacting with Borealin. In mitosis, the 
active cyclin B1/Cdk1 phosphorylates MLL5 and leads to its dissociation from the 
chromatin. Meanwhile Borealin is phosphorylated by Cdk1 and associates with the 
centromeric adaptor Shugoshin. At the same time, phosphorylation of Thr3 on histone 
H3 by Haspin recruits Survivin onto the centromeric region of the chromatin. The 
interactions between Borealin-Shugoshin and Survivin-phosphohistoneH3 Thr3 





5.2 The phosphorylation regulation of MLL5 
In this study, we have documented the dynamic phosphorylation modification on 
MLL5 during mitosis and the redistribution of phosphorylated MLL5 in mitotic cells. 
The phosphorylation and localization of MLL5 are dependent on the Cdk1 kinase 
activity. The functional significance of phosphorylation modification is revealed by 
the inability of the MLL5ΔCD-4 and MLL5-T912A mutants to compensate for the 
loss of endogenous MLL5. We have previously shown that MLL5 participates in the 
cell cycle regulatory machinery at multiple stages of the cell cycle. The data presented 
here further elucidate the molecular mechanisms of MLL5 in G2/M transition. So far, 
this is the only report on cell cycle-dependent phosphorylation regulation among 
MLL family members. The precursor MLL1 undergoes evolutionarily conserved site-
specific cleavage by Taspase1. Following processing, C-terminal MLL appears to 
undergo phosphorylation (Yokoyama et al., 2002). However, the regulation of MLL 
phosphorylation and the functional consequence of such phosphorylation remain 
undetermined. 
 
MLL5 has been implicated in cell cycle and differentiation regulation via directly 
binding to the regulatory region of a target gene, or indirectly modulating a hierarchy 
of chromatin and transcriptional regulators. The mitotic phosphorylation modification 
appears to lead to the sub-cellular redistribution of MLL5, perhaps to prevent it from 
reaching downstream targets while repressing the interphase transcriptional program. 
Indeed, at the onset of mitosis, many transcriptional and chromatin remodeling factors 
are excluded from chromatin, which correlated with global transcriptional silencing 
and chromosome condensation (Delcuve et al., 2008). A common mechanism 
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involved in the chromosomal exclusion is the intrinsic and systematic modifications 
on hitone H3 protein, which facilitates chromatin condensation and confers the 
topological specificity to mitotic chromosomes (Georgatos et al., 2009; Ito, 2007). 
Studies on MLL1 in cell cycle demonstrate that in interphase, MLL1 coordinates the 
expression of cyclins to ensure proper cell cycle transition and the expression of the 
cyclin-dependent kinase inhibitors to suppress cell proliferation (Milne et al., 2005). 
In mitosis, most of MLL1 and MLL1-interacting proteins (CGBP, Ash2, Rbbp5) 
dissociate from condensed chromatin, spread into the cytoplasm, except a small 
amount of MLL1 is still associated with actively transcribed Hox gene promoter 
(Mishra et al., 2009). A genome-wide RNAi profiling study has suggested that MLL5 
may form a protein complex, homologous to the yeast orthologues SET3 complex, 
with NcoR2 and TLB1X functioning as transcription repressors during cytokinesis 
(Kittler et al., 2007). It is plausible that the phosphorylation modification on MLL5 
may serve as a “molecular switch” to signal the protein complex to dissociate from 
mitotic chromosomes in order to turn on the mitotic program. Previous investigation 
on cell cycle suggest that over-expression or down-regulation of MLL5 inhibits cell 
proliferation possibly via modulating p21 and pRb pathways (Cheng et al., 2008). The 
present study demonstrates that perturbation in MLL5 phosphorylation, either by 
over-expression of phospho-domain deletion or Thr912Ala mutant, associates with 
impaired mitotic progression. Collectively, these data imply that the cell-cycle 
regulatory function of MLL5 not only depends on protein abundance, but also relies 





5.3 MLL5 and the chromosomal passenger complex 
Studies on the molecular functions of CPC provide important mechanistic insights 
into the mitotic regulation, ranging from kinetochore-microtubule interactions to 
chromatid cohesion to cytokinesis, and constitute one of the most dynamic areas of 
ongoing research on cell cycle. In this study, we revealed a novel mechanism 
explaining how the stability of CPC can be modulated by MLL5. Borealin interacts 
with MLL5 directly and the interaction plays a critical role in maintaining its stability. 
In MLL5 knockdown cells, the stability of Borealin is severely compromised, which 
causes the destabilization of Aurora B, Survivin and INCENP. This claim could be 
challenged by a previous study which showed that Borealin-siRNA causes the 
instability of Survivin but not of Aurora B and INCENP (Gassmann et al., 2004). 
However, Honda and his colleagues demonstrated that Survivin-siRNA treatment 
resulted in a substantial reduction in the expression of Aurora B and INCENP (Honda 
et al., 2003). In light of the effects of Survivin on the stability of Aurora B and 
INCENP, it is likely that the destabilization of Borealin in MLL5 knockdown cells 
causes the degradation of Aurora B and INCENP directly or indirectly through the 
destabilization of Survivin. The contradictory observation obtained by us and 
Gassmann’s group could be due to cell-type specificity or western blotting sensitivity. 
Nonetheless, our data clearly suggest that MLL5-siRNA treatment results in down-
regulation of Borealin, which in turn leads to the destruction of Aurora B, Survivin 
and INCENP. Moreover, the recruitment of CPC to the centromere region of 
chromatin has been suggested to be mediated by the interaction between Borealin and 
centromere adaptor Shugoshin (Kelly et al., 2010; Tsukahara et al., 2010; Wang et al., 
2010). Thus it is likely that MLL5 not only functions as a molecular chaperone for 
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Borealin in interphase, but also brings Borealin and its chromatin targets into close 
proximity, thus allowing the recruitment of CPC to the centromere region. 
 
Eukaryotic cells have a sophisticated system for regulating the protein turnover, in 
which proteins are attached with polyubiquitin chains and directed to the proteasome 
for degradation (Glickman and Ciechanover, 2002).   This system removes mis-folded 
proteins and also gets rid of native proteins for regulatory purposes. The mammalian 
70-kDa and 90-kDa heat-shock protein (HSP70 and HSP90) families, which are 
molecular chaperones required for the conformational maturation and/or stability of a 
range of proteins, cooperate closely with the ubiquitin-proteasome system to 
orchestrate the proper cell cycle progression and successful completion of mitosis 
(Burrows et al., 2004; Young et al., 2004). In particular, systematic study has 
uncovered the diverse cellular functions of the HSP90, including involvement of 
HSP90 in various secretory pathways, cellular transport, cell cycle, cytokinesis and 
meiosis (McClellan et al., 2007). The CPC component Survivin has been shown to 
interact with HSP90 and disruption of the interaction destabilizes Survivin, resulting 
in mitotic defects and mitochondrial-dependent apoptosis (Fortugno et al., 2003). 
Similarly, Polo like kinase is also under the HSP90 molecular chaperone regulation, 
in which SGT1 serves as a co-chaperone of HSP90 in stabilizing the kinase, allowing 
normal centrosome maturation, entry and progression through mitosis (de Carcer et al., 
2001; Martins et al., 2009). Mutations in SGT1 severely compromise the organization 
and function of the mitotic apparatus (Martins et al., 2009). These studies further 
prompt us to speculate that the role of MLL5 in mitotic regulation might be like a 
molecular co-chaperone, where it cooperates with the chaperone proteins to maintain 
the stability of the CPC, and facilitates the proper mitotic progression. Therefore, a 
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potential cooperation between MLL5 and HSP90 in the control of mitosis might be an 
exciting possibility and deserves further investigation. 
 
The post-translational regulation of CPC has been investigated intensively. The kinase 
Aurora-B is ubiquitinated and degraded at the end of mitosis via the APC/C pathway 
(Nguyen et al., 2005; Stewart and Fang, 2005), and the involvement of the ubiquitin-
proteasome pathway in the regulation of Survivin has also been reported (Zhao et al., 
2000). In addition, SUMOylation and phosphorylation modification also modulate the 
function of the CPC. Borealin protein is recently discovered as a target of SUMO in 
early mitosis, and phosphorylation of Borealin by Mps1 controls Aurora-B activity 
and chromosome alignment (Jelluma et al., 2008; Klein et al., 2009). In this study, we 
demonstrated that depletion of MLL5 causes the down-regulation of Borealin via the 
proteasome-mediated degradation, which leads to the destruction of the CPC. 
Although the specific E3 ubiquitin ligase which is responsible for substrate 
recognition has yet to be determined, our study reveals the presence of a multilayered 
regulatory network to modulate the expression and stability of the CPC. 
 
Research on the molecular functions of CPC provide important mechanistic insights 
into the mitotic regulation, ranging from kinetochore-microtubule interactions to 
chromatid cohesion to  cytokinesis, and constitute one of the most dynamic areas of 
ongoing studies on cell cycle. The expression of CPC is commonly known to be 
transcriptionally regulated, and the Forkhead box m1 (FoxM1) protein has been 
demonstrated to be essential for the transcription of Aurora-B and Survivin in mitosis 
(Wang et al., 2005). It is also reported that Borealin is repressed in response to 
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p53/Rb signaling and is up-regulated in cancerous tissues (Date et al., 2007). Since 
down-regulation of MLL5 causes the activation of p53 and dephosphorylation of Rb 
in a broad range of human cell lines (Cheng et al., 2008), we would expect to see the 
decrease in the mRNA level of Borealin in MLL5-depleted cells. However, in this 
study we did not manage to establish a positive link between MLL5 and the 
expression of Borealin, which could be due to the samples used in this study were 
from mitotic cells, where MLL5 already dissociates from chromatin and is unlikely to 
play a role in transcriptional regulation. Hence the potential function of MLL5 on the 
transcriptional regulation of CPC in interphase is still obscure and awaits 
experimental validation. 
 
5.4 MLL5 and the spindle assembly checkpoint 
The chromosomal passenger complex has been implicated in spindle assembly 
checkpoint signaling (Figure 1-4). With the development of small molecule inhibitor 
of Aurora B, mechanisms on how the spindle checkpoint signaling is regulated by 
CPC are revealed. When the Aurora B function is inhibited by small molecule 
inhibitor ZM447439, not only the kinetochore localization of BubR1 is diminished in 
nocodazole-treated cells, but also the recruitment of BubR1 to metaphase 
kinetochores after loss of inter-kinetochore tension is prevented (Ditchfield et al., 
2003).  Furthermore, loss of Aurora B function does not override the mitotic 
checkpoint activated by the depolymerization of microtubules; however, cells without 
functional Aurora B cannot sustain mitotic arrest in response to taxol or monastrol 
(Hauf et al., 2003; Morrow et al., 2005). In this study, we have detected the loss of 
BubR1 staining from kinetochores in MLL5-depleted cells after the depolymerization 
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of microtubules by nocodazole (Figure 4-7). We also observed that the activation of 
the spindle assembly checkpoint was not affected in MLL5-depleted cells after 
treating with microtubule-damaging drugs (nocodazole and taxol); however, MLL5-
depleted cells could not maintain prolonged mitotic arrest as compared to the NC-
siRNA treated cells (Figure 4-8). These characteristics are similar as the phenotypes 
produced by Aurora B inhibition. In light of the important function of Aurora B in the 
spindle checkpoint activation and maintenance, the delocalization of BubR1 observed 
in MLL5-depleted cells might be a secondary effect resulting from the loss-of-
function of the CPC. In other words, MLL5 might have an indirect role in spindle 
assembly checkpoint signaling through the activity of the chromosomal passenger 
complex.   
 
5.5 MLL5 in genomic stability maintenance and tumor suppression 
Loss of chromosomal stability and genomic integrity is the principle driving force for 
carcinogenesis and tumor progression. Here we demonstrated that depletion of MLL5 
causes the degradation of the CPC and the induction of genomic instability. Since the 
correlations between altered function of CPC and deregulated mitosis are well 
understood (Kallio et al., 2002), our findings suggest of a role of MLL5 in tumor 
suppression. Recently, the down regulation of MLL5 in response to anti-cancer drug 
camptothecin treatment was observed in human cell lines and zebrafish (Cheng et al., 
2011); interestingly the correlation between the expression of MLL5 and favorable 
treatment outcome has just been established in a clinical study for AML patients 
(Damm et al., 2011). Therefore, it is reasonable to speculate that if an anticancer drug 
induces the down regulation of MLL5, the tumor cells may undergo mitotic slippage 
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due to the degradation of the CPC. In some cases, these cells may continue to divide 
and become resistant to chemotherapy (Swanton et al., 2007; Weaver and Cleveland, 
2005). Altogether, these evidence support that MLL5 may function as a “guardian of 
the genome” in mitotic regulation and in the maintenance of genomic stability. Our 
study also sheds light on anti-cancer treatment, in which the expression level of 
MLL5 in patients and whether the treatment regime affects the cellular level of MLL5 
should be taken into consideration. 
CHAPTER 6- FUTURE DIRECTIONS 
6.1 Identification of phosphorylation modification on MLL5 by systematic 
approach 
Although alteration of the electrophoretic mobility of a target protein upon 
phosphorylation modification has been well documented, it is still quite surprising 
that a change in gel mobility for such a big protein (>200 kDa) could be detected by a 
denaturing polyacrylamide gel. One possible explanation is that the addition of a 
phosphate group on MLL5 not only makes changes to the molecular mass, but alters 
the protein’s conformation, causing differential denaturation by SDS and thus 
inducing changes in the protein’s migration that is not strictly in line with molecular 
mass (Reynolds and Tanford, 1970). Another possible explanation is that numerous 
Ser and Thr residues clustered within the CD-4 domain are phosphorylated at mitosis. 
Indeed, the 333-residue CD-4 domain is rich in Ser and Thr (38 Ser and 35 Thr 
residues). Although in this study Thr912 was identified to be a critical Cdk1-targeting 
site as the mutation of Thr to Ala completely abrogated the mitotic phosphorylation of 
MLL5, the possibility that additional phosphorylation by other kinases may occur 
upon Thr912 phosphorylation cannot be ruled out. Hence, for such a Ser/Thr-rich 
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region, high-resolution mass spectrometry will be a more systematic approach to map 
out the phosphorylation sites on MLL5 in mitosis (Zhou et al., 2001).   
 
6.2 Characterization of other post-translational modification on MLL5 
Cdk1 is the main mitotic kinase controlling the onset of mitosis by phosphorylating a 
range of substrates involved in mitotic activation, nuclear envelope breakdown, 
chromosome condensation and mitotic spindle formation. Studies have shown that 
phosphorylation by Cdk1 may create a docking site for other mitotic kinases, such as 
PLK1 to regulate mitotic progression in later stages (Elia et al., 2003; Neef et al., 
2007). Therefore, phosphorylation on Thr912 residue by Cdk1 may serve as a priming 
site on MLL5, leading to the recruitment of other mitotic kinases to participate in the 
downstream phosphorylation events. Upon phosphorylation, MLL5 may undergo 
subsequent post-translational modifications that are phosphorylation-dependent. 
Growing evidence has highlighted a crucial role of phosphorylation modification in 
signal transduction and crosstalk with other protein posttranslational modifications 
(Hunter, 2007). Further investigation of subsequent mitotic events upon 
phosphorylation of Thr912 on MLL5, and the de-phosphorylation mechanism of 
MLL5 at mitotic exit, will address in greater detail how the mitotic cascade is 
regulated. 
 
Although the histone methyltransferase activity of MLL5 is yet to be fully 
characterized, a recent report by Fujiki et al. suggested that a short isoform but not the 
full-length MLL5 possesses GlcNAcylation-dependent HKMT activity, facilitating 
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retinoic-acid-induced granulopoiesis (Fujiki et al., 2009). Therefore, tightly-regulated 
phosphorylation of MLL5 during mitosis may coordinate with its mitotic chromatin 
regulatory roles to ensure proper mitotic progression. It will be intriguing to test 
whether such phosphorylation signal may be a fine-tuning factor for its epigenetic 
activity. As demonstrated by Sampath et al., autocatalytic methylation of H3K9 G9a 
methylase is necessary to mediate in vivo interaction with heterochromatin protein 1 
(HP1), and this methyl-dependent interaction can be reversed by adjacent G9a 
phosphorylation (Sampath et al., 2007). Similar phosphorylation at G2/M phase has 
been reported for PR-Set7 H4K20 methylase and its catalytic function is known to 
play a critical role in mitosis and S-phase progression (Georgi et al., 2002; Rice et al., 
2002; Tardat et al., 2007). 
 
6.3 MLL5 in mitotic spindle regulation 
In this study, we found that multipolar mitosis accounts for ~40% of the mitotic 
population in cells lacking of MLL5, which can be explained by the down regulation 
of the CPC, since the involvement of Aurora-B, Survivin and Borealin in sustained 
spindle checkpoint activation and spindle integrity has already been reported 
(Gassmann et al., 2004; Lens et al., 2003; Santaguida et al., 2011). However, the 
origin of the multipolar mitosis is very diverse, which can arise from over-
amplification of centrosomes, interference with microtubule dynamics or spindle 
integrity defects (Oshimori et al., 2006; Tsou and Stearns, 2006; Yang et al., 2008).  
Therefore we cannot exclude the possibility that MLL5-knockdown induces 
multipolar mitosis through other mechanisms. In fact, one of the projects in our lab is 
to explore the role of MLL5 in centrosome regulation, and our preliminary data 
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suggest that a fraction of MLL5 localizes to centrosomes and it possibly maintains 
centrosome integrity by regulating the recruitment of PLK1 onto the centrosomes. It 
is well known that centrosomes have a crucial role in the formation of bipolar mitotic 
spindles, which is essential for the accurate segregation of chromosomes (Nigg and 
Raff, 2009). Growing volume of evidence have shown that mutations of certain 
oncogenes and tumor suppressors disrupt the numeral and functional integrity of 
centrosomes and directly result in chromosome instability (Fukasawa, 2007). 
Moreover, chromatin remodeling proteins (Chromodomain helicase DNA 
binding protein 3 and 4 (CHD3 and CHD4)) have also been demonstrated to play a 
role in regulating the centrosome integrity by modulating the centrosomal anchoring 
of pericentrin/γ-tubulin (Sillibourne et al., 2007). Taken together, finding the 
mechanism by which MLL5 regulates the centrosome function may shed light on the 
understanding of this protein and help to build a picture of the mitotic signaling of 
MLL5. 
 
6.4 MLL5 in meiosis 
The present study investigates the molecular function of MLL5 in mitosis regulation, 
and demonstrates that depletion of MLL5 results in mitotic defects due to the 
degradation of the CPC, which is essential to regulate the attachments of kinetochores 
to microtubules, to ensure proper mitotic checkpoint function and for cytokinesis. It is 
also well established that CPC is required for the fidelity of chromosome transmission 
and cytokinesis in meiosis (Sharif et al., 2010). Unlike other metazoans that have only 
the B-form of Aurora kinase in the CPC, vertebrates have another form, known as 
Aurora C, which is highly expressed in germ line and is implicated in 
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spermatogenesis (Hu et al., 2000; Tang et al., 2006). In mitotic cells, Aurora C kinase 
can interact with INCENP and complement Aurora B function, suggesting that these 
two kinases have overlapping functions in mitosis (Sasai et al., 2004). While in 
meiosis, expression of the inactive Aurora B results in abnormal spermatocytes, 
increased apoptosis and subfertility defects; loss of Aurora C function induces 
heterogenous chromatin condensation in sperm and male mice have compromised 
fertility (Kimmins et al., 2007). These data suggest that Aurora B and Aurora C may 
serve specialized functions in meiotic regulation.   
In view of the importance of CPC in both mitosis and meiosis, and the down-
regulation of CPC after MLL5-depletion, it is reasonable to further investigate the 
potential function of MLL5 in meiosis regulation. Experiments on Mll5 knockout 
mice have shown that male Mll5-deficient mice are infertile (Heuser et al., 2009; 
Madan et al., 2009; Zhang et al., 2009), and it has recently been revealed that Mll5-
deficient mice have defects in terminal maturation and packaging of sperm (Yap et al., 
2011). Although microarray analysis identify some transcripts that are relevant to 
spermatogenesis are dysregulated in Mll5-knockout mice (Yap et al., 2011), further 
validation of these potential targets is required. Based on our findings that MLL5 has 
an impact on the expression of Aurora B through interacting with Borealin, we 
speculate that the spermatogenesis defects observed in Mll5-deficient mice might be 
possibly due to the deregulation of CPC function. Thus, it will be intriguing to 
compare the expression and function of the CPC in wild-type and Mll5-deficient germ 




The network of signaling pathways involved in mitotic regulation has been 
extensively investigated in the past decades. Results from this study clearly indicate 
that the expression and phosphorylation modification of MLL5 at G2/M phase has to 
be closely regulated for the faithful mitotic progression. The evidences presented in 
this thesis have revealed the importance of the interplay of MLL5, cyclin B1/Cdk1 
and CPC in mitotic regulation, and furthered our understandings on the molecular 
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